activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	395341	CHEMBL772117	Inhibition of Protein kinase C mu	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	>	IC50	nM	100000.0	CHEMBL3863	Homo sapiens	IC50	uM	100.0
	395341	CHEMBL772117	Inhibition of Protein kinase C mu	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	>	IC50	nM	100000.0	CHEMBL3863	Homo sapiens	IC50	uM	100.0
	1483087	CHEMBL835532	Percentage inhibition of Protein kinase C mu at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Activity	%	88.0	CHEMBL3863	Homo sapiens	Activity	%	88.0
	1483099	CHEMBL835532	Percentage inhibition of Protein kinase C mu at 50 uM	B	CCCCCNC1=C(c2cn(C)c3ccccc23)C(=O)N(C)C1=O		CHEMBL365337	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	1727577	CHEMBL859766	Inhibition of human PKC mu at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	3.0	CHEMBL3863	Homo sapiens	Inhibition	%	3.0
	1734110	CHEMBL862826	Residual activity at human PKCmu at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	98.0	CHEMBL3863	Homo sapiens	Activity	%	98.0
	1769433	CHEMBL910944	Inhibition of PKCmu	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	uM	1.0
	1790020	CHEMBL854688	Percentage activity of human PKC mu in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
	1790373	CHEMBL856399	Percent residual activity, relative to control, of PKD1 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	9.0	CHEMBL3863	Homo sapiens	Activity	%	9.0
	1790427	CHEMBL856399	Percent residual activity, relative to control, of PKD1 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	54.0	CHEMBL3863	Homo sapiens	Activity	%	54.0
	1904611	CHEMBL889567	Inhibition of PKCmu	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	uM	1.0
	1981755	CHEMBL899271	Inhibition of PKD1 assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	81.0	CHEMBL3863	Homo sapiens	Activity	%	81.0
	1981756	CHEMBL899272	Inhibition of PKD1 assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	73.0	CHEMBL3863	Homo sapiens	Activity	%	73.0
	2025186	CHEMBL887013	Inhibition of human PKCmu at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	118.0	CHEMBL3863	Homo sapiens	Inhibition	%	118.0
	2025450	CHEMBL887013	Inhibition of human PKCmu at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	110.0	CHEMBL3863	Homo sapiens	Inhibition	%	110.0
	2025451	CHEMBL887013	Inhibition of human PKCmu at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	113.0	CHEMBL3863	Homo sapiens	Inhibition	%	113.0
	2025452	CHEMBL887013	Inhibition of human PKCmu at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	118.0	CHEMBL3863	Homo sapiens	Inhibition	%	118.0
	2077623	CHEMBL944997	Inhibition of PKD1	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Inhibition	%	60.0	CHEMBL3863	Homo sapiens	Inhibition	%	60.0
	2147360	CHEMBL922145	Activity of human PKCmu kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	112.0	CHEMBL3863	Homo sapiens	Activity	%	112.0
Not Evaluated	2149602	CHEMBL931299	Inhibition of human PKC mu	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL3863	Homo sapiens	Activity		
	2206992	CHEMBL966758	Inhibition of PKCmu	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	uM	10.0
	2251065	CHEMBL1011940	Inhibition of PKCmu at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	54.0	CHEMBL3863	Homo sapiens	INH	%	54.0
	2251218	CHEMBL1009916	Inhibition of PKCmu	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL3863	Homo sapiens	IC50	nM	10.0
Not Active	2302195	CHEMBL950864	Inhibition of human PKD1 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	2470322	CHEMBL992499	Inhibition of PRKD1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3863	Homo sapiens	INH	%	10.0
	2635902	CHEMBL1003332	Inhibition of PKD1 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	75.0	CHEMBL3863	Homo sapiens	Residual_activity	%	75.0
	2635970	CHEMBL1003332	Inhibition of PKD1 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	75.0	CHEMBL3863	Homo sapiens	Residual_activity	%	75.0
	2636038	CHEMBL1003332	Inhibition of PKD1 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL3863	Homo sapiens	Residual_activity	%	75.0
	2721696	CHEMBL1054323	Inhibition of PKCmu at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	2894647	CHEMBL1062020	Percentage PKD1 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	84.0	CHEMBL3863	Homo sapiens	Activity	%	84.0
	2894648	CHEMBL1062020	Percentage PKD1 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	63.0	CHEMBL3863	Homo sapiens	Activity	%	63.0
	2894649	CHEMBL1062020	Percentage PKD1 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	83.0	CHEMBL3863	Homo sapiens	Activity	%	83.0
	2894650	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	63.0	CHEMBL3863	Homo sapiens	Activity	%	63.0
Antagonist	2894651	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	38.0	CHEMBL3863	Homo sapiens	Activity	%	38.0
Antagonist	2894652	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	23.0	CHEMBL3863	Homo sapiens	Activity	%	23.0
	2894653	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	85.0	CHEMBL3863	Homo sapiens	Activity	%	85.0
	2894654	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	66.0	CHEMBL3863	Homo sapiens	Activity	%	66.0
Antagonist	2894655	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	5.0	CHEMBL3863	Homo sapiens	Activity	%	5.0
	2894656	CHEMBL1060156	Percentage PKD1 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	91.0	CHEMBL3863	Homo sapiens	Activity	%	91.0
	2894657	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	85.0	CHEMBL3863	Homo sapiens	Activity	%	85.0
	2894658	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	90.0	CHEMBL3863	Homo sapiens	Activity	%	90.0
	2894659	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
Antagonist	2894660	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	46.0	CHEMBL3863	Homo sapiens	Activity	%	46.0
Antagonist	2894661	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	43.0	CHEMBL3863	Homo sapiens	Activity	%	43.0
	2894662	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	54.0	CHEMBL3863	Homo sapiens	Activity	%	54.0
	2894663	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	106.0	CHEMBL3863	Homo sapiens	Activity	%	106.0
Antagonist	2894664	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	40.0	CHEMBL3863	Homo sapiens	Activity	%	40.0
	2894665	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	71.0	CHEMBL3863	Homo sapiens	Activity	%	71.0
Antagonist	2894666	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	31.0	CHEMBL3863	Homo sapiens	Activity	%	31.0
	2894667	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	64.0	CHEMBL3863	Homo sapiens	Activity	%	64.0
Antagonist	2894668	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	28.0	CHEMBL3863	Homo sapiens	Activity	%	28.0
Antagonist	2894669	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	21.0	CHEMBL3863	Homo sapiens	Activity	%	21.0
	2894670	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	86.0	CHEMBL3863	Homo sapiens	Activity	%	86.0
	2894671	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
Antagonist	2894672	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	8.0	CHEMBL3863	Homo sapiens	Activity	%	8.0
Antagonist	2894673	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	3.0	CHEMBL3863	Homo sapiens	Activity	%	3.0
	2894674	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	104.0	CHEMBL3863	Homo sapiens	Activity	%	104.0
	2894675	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	90.0	CHEMBL3863	Homo sapiens	Activity	%	90.0
	2894676	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	89.0	CHEMBL3863	Homo sapiens	Activity	%	89.0
	2894677	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	108.0	CHEMBL3863	Homo sapiens	Activity	%	108.0
	2894678	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	83.0	CHEMBL3863	Homo sapiens	Activity	%	83.0
	2894679	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	77.0	CHEMBL3863	Homo sapiens	Activity	%	77.0
	2894680	CHEMBL1060157	Percentage PKD1 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	82.0	CHEMBL3863	Homo sapiens	Activity	%	82.0
	2894681	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
	2894682	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	2894683	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	2894684	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	86.0	CHEMBL3863	Homo sapiens	Activity	%	86.0
	2894685	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	2894686	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	82.0	CHEMBL3863	Homo sapiens	Activity	%	82.0
	2894687	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	86.0	CHEMBL3863	Homo sapiens	Activity	%	86.0
	2894688	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	78.0	CHEMBL3863	Homo sapiens	Activity	%	78.0
	2894689	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	61.0	CHEMBL3863	Homo sapiens	Activity	%	61.0
	2894690	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	2894691	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	90.0	CHEMBL3863	Homo sapiens	Activity	%	90.0
	2894692	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	91.0	CHEMBL3863	Homo sapiens	Activity	%	91.0
	2894693	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	87.0	CHEMBL3863	Homo sapiens	Activity	%	87.0
	2894694	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	81.0	CHEMBL3863	Homo sapiens	Activity	%	81.0
	2894695	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	26.0	CHEMBL3863	Homo sapiens	Activity	%	26.0
	2894696	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	108.0	CHEMBL3863	Homo sapiens	Activity	%	108.0
	2894697	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	80.0	CHEMBL3863	Homo sapiens	Activity	%	80.0
Antagonist	2897339	CHEMBL1051270	Inhibition of PKD1 in the presence of 50uM ATP	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	9100.0	CHEMBL3863	Homo sapiens	IC50	uM	9.1
Antagonist	2897340	CHEMBL1051270	Inhibition of PKD1 in the presence of 50uM ATP	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	IC50	nM	900.0	CHEMBL3863	Homo sapiens	IC50	uM	0.9
Antagonist	2897341	CHEMBL1051270	Inhibition of PKD1 in the presence of 50uM ATP	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	250.0	CHEMBL3863	Homo sapiens	IC50	uM	0.25
	2905492	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905493	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905494	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1200.0	CHEMBL3863	Homo sapiens	Kd	nM	1200.0
	2905495	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905496	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905497	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1200.0	CHEMBL3863	Homo sapiens	Kd	nM	1200.0
	2905498	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905499	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905500	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905501	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905502	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2905503	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906293	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906294	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906295	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	520.0	CHEMBL3863	Homo sapiens	Kd	nM	520.0
	2906296	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906297	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906298	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906299	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906300	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	8400.0	CHEMBL3863	Homo sapiens	Kd	nM	8400.0
	2906301	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906302	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906303	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906304	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906305	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906306	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906307	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906308	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906309	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906310	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906311	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906312	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906313	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	27.0	CHEMBL3863	Homo sapiens	Kd	nM	27.0
	2906314	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2400.0	CHEMBL3863	Homo sapiens	Kd	nM	2400.0
	2906315	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3863	Homo sapiens	Kd	nM	310.0
	2906316	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906317	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2906318	CHEMBL1061155	Binding constant for PRKD1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	2908022	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	111.0	CHEMBL3863	Homo sapiens	Activity	%	111.0
	2908023	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	88.0	CHEMBL3863	Homo sapiens	Activity	%	88.0
	2908024	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	108.0	CHEMBL3863	Homo sapiens	Activity	%	108.0
	2908025	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	99.0	CHEMBL3863	Homo sapiens	Activity	%	99.0
	2908026	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	56.0	CHEMBL3863	Homo sapiens	Activity	%	56.0
	2908027	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	87.0	CHEMBL3863	Homo sapiens	Activity	%	87.0
	2908028	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	94.0	CHEMBL3863	Homo sapiens	Activity	%	94.0
Antagonist	2908029	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	35.0	CHEMBL3863	Homo sapiens	Activity	%	35.0
	2908030	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
Antagonist	2908031	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	13.0	CHEMBL3863	Homo sapiens	Activity	%	13.0
	2908032	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	2908033	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	90.0	CHEMBL3863	Homo sapiens	Activity	%	90.0
Antagonist	2908034	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	19.0	CHEMBL3863	Homo sapiens	Activity	%	19.0
	2908035	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	81.0	CHEMBL3863	Homo sapiens	Activity	%	81.0
	2908036	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	76.0	CHEMBL3863	Homo sapiens	Activity	%	76.0
	2908037	CHEMBL1062021	Percentage PKD1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	76.0	CHEMBL3863	Homo sapiens	Activity	%	76.0
	2908038	CHEMBL1061098	Percentage PKD1 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	62.0	CHEMBL3863	Homo sapiens	Activity	%	62.0
	2908039	CHEMBL1061098	Percentage PKD1 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	60.0	CHEMBL3863	Homo sapiens	Activity	%	60.0
	2908040	CHEMBL1062774	Percentage PKD1 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	2908041	CHEMBL1060215	Percentage PKD1 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	83.0	CHEMBL3863	Homo sapiens	Activity	%	83.0
	2921195	CHEMBL1058403	Inhibition of PRKD1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	2924753	CHEMBL1056861	Inhibition of PKD1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	71.0	CHEMBL3863	Homo sapiens	Activity	%	71.0
	2924754	CHEMBL1056861	Inhibition of PKD1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	83.0	CHEMBL3863	Homo sapiens	Activity	%	83.0
	2924755	CHEMBL1056861	Inhibition of PKD1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	87.0	CHEMBL3863	Homo sapiens	Activity	%	87.0
	2924756	CHEMBL1056861	Inhibition of PKD1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	28.0	CHEMBL3863	Homo sapiens	Activity	%	28.0
	2926209	CHEMBL1050221	Inhibition of PKD1 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	2928395	CHEMBL1060293	Inhibition of PKD1 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	2938453	CHEMBL1041412	Inhibition of PRKD1 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	43.0	CHEMBL3863	Homo sapiens	INH	%	43.0
	2999001	CHEMBL1041973	Inhibition of PKD1 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	60.0	CHEMBL3863	Homo sapiens	Activity	%	60.0
	2999791	CHEMBL1041973	Inhibition of PKD1 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	89.0	CHEMBL3863	Homo sapiens	Activity	%	89.0
	2999868	CHEMBL1048113	Inhibition of PKD1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	88.0	CHEMBL3863	Homo sapiens	Activity	%	88.0
	2999944	CHEMBL1048113	Inhibition of PKD1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	3052451	CHEMBL1072489	Residual activity of PKCmu at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	81.0	CHEMBL3863	Homo sapiens	Residual activity	%	81.0
	3052703	CHEMBL1040280	Residual activity of PKCmu at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	89.0	CHEMBL3863	Homo sapiens	Residual activity	%	89.0
	3054012	CHEMBL1050343	Residual activity of PKCmu at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	111.0	CHEMBL3863	Homo sapiens	Residual activity	%	111.0
	3054264	CHEMBL1072489	Residual activity of PKCmu at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	91.0	CHEMBL3863	Homo sapiens	Residual activity	%	91.0
	3055551	CHEMBL1040280	Residual activity of PKCmu at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	89.0	CHEMBL3863	Homo sapiens	Residual activity	%	89.0
	3056856	CHEMBL1050343	Residual activity of PKCmu at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	122.0	CHEMBL3863	Homo sapiens	Residual activity	%	122.0
	3057108	CHEMBL1072489	Residual activity of PKCmu at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	102.0	CHEMBL3863	Homo sapiens	Residual activity	%	102.0
	3058428	CHEMBL1040280	Residual activity of PKCmu at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL3863	Homo sapiens	Residual activity	%	100.0
	3059712	CHEMBL1050343	Residual activity of PKCmu at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	126.0	CHEMBL3863	Homo sapiens	Residual activity	%	126.0
	3130783	CHEMBL1065110	Inhibition of PKD1 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3131778	CHEMBL1065782	Inhibition of PKD1 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3214023	CHEMBL1103218	Inhibition of PKD1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL3863	Homo sapiens	INH	%	2.0
	3219697	CHEMBL1110448	Inhibition of PKCmu at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	93.0	CHEMBL3863	Homo sapiens	INH	%	93.0
	3224937	CHEMBL1101490	Inhibition of PKCmu at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3226316	CHEMBL1101490	Inhibition of PKCmu at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3261343	CHEMBL1108062	Inhibition of PKD1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	14.0	CHEMBL3863	Homo sapiens	Activity	%	14.0
	3261367	CHEMBL1108062	Inhibition of PKD1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	18.0	CHEMBL3863	Homo sapiens	Activity	%	18.0
	3306943	CHEMBL1118067	Inhibition of PKD1 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	73.0	CHEMBL3863	Homo sapiens	INH	%	73.0
	3329240	CHEMBL1166747	Inhibition of PKCmu	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	IC50	nM	650.0	CHEMBL3863	Homo sapiens	IC50	uM	0.65
	3332114	CHEMBL1166825	Inhibition of PRKD1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	Inhibition	%	67.0	CHEMBL3863	Homo sapiens	INH	%	67.0
	3333529	CHEMBL1166825	Inhibition of PRKD1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3334934	CHEMBL1166825	Inhibition of PRKD1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3336354	CHEMBL1166825	Inhibition of PRKD1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	67.0	CHEMBL3863	Homo sapiens	INH	%	67.0
	3341896	CHEMBL1166825	Inhibition of PRKD1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3343343	CHEMBL1166825	Inhibition of PRKD1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	3358769	CHEMBL1175235	Inhibition of PRKD1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	51.0	CHEMBL3863	Homo sapiens	INH	%	51.0
	3359211	CHEMBL1175235	Inhibition of PRKD1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	63.0	CHEMBL3863	Homo sapiens	INH	%	63.0
	3407877	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Activity	%	2.0	CHEMBL3863	Homo sapiens	Activity	%	2.0
	3407878	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	Activity	%	3.0	CHEMBL3863	Homo sapiens	Activity	%	3.0
	3407887	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	IC50	nM	27.0	CHEMBL3863	Homo sapiens	IC50	nM	27.0
	3407888	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	321.0	CHEMBL3863	Homo sapiens	IC50	nM	321.0
	3407889	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	OCCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214930	>	IC50	nM	40000.0	CHEMBL3863	Homo sapiens	IC50	nM	40000.0
	3407890	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CNc1cc(-c2cc3cnccc3c(NCCCO)n2)ccn1		CHEMBL1214931	=	IC50	nM	764.0	CHEMBL3863	Homo sapiens	IC50	nM	764.0
	3407891	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214932	=	IC50	nM	59.0	CHEMBL3863	Homo sapiens	IC50	nM	59.0
	3407892	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	Clc1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214933	=	IC50	nM	50.0	CHEMBL3863	Homo sapiens	IC50	nM	50.0
	3407893	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	IC50	nM	0.6	CHEMBL3863	Homo sapiens	IC50	nM	0.6
	3407894	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	IC50	nM	62.0	CHEMBL3863	Homo sapiens	IC50	nM	62.0
	3407895	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	5420.0	CHEMBL3863	Homo sapiens	IC50	nM	5420.0
	3407896	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	OCCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214930	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	nM	10000.0
	3407897	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CNc1cc(-c2cc3cnccc3c(NCCCO)n2)ccn1		CHEMBL1214931	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	nM	10000.0
	3407898	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214932	=	IC50	nM	2096.0	CHEMBL3863	Homo sapiens	IC50	nM	2096.0
	3407899	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	Clc1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214933	=	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	nM	1000.0
	3407900	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	IC50	nM	32.0	CHEMBL3863	Homo sapiens	IC50	nM	32.0
	3407905	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1ccc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2c1		CHEMBL1215505	=	IC50	nM	12.0	CHEMBL3863	Homo sapiens	IC50	nM	12.0
	3407906	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cnc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2c1		CHEMBL1215570	=	IC50	nM	695.0	CHEMBL3863	Homo sapiens	IC50	nM	695.0
	3407907	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc2cc(-c3ccnc(NC4CCCCC4)c3)nc(N3CCNCC3)c2cn1		CHEMBL1215571	=	IC50	nM	191.0	CHEMBL3863	Homo sapiens	IC50	nM	191.0
	3407908	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cnc2cc(-c3ccnc(NC4CCCCC4)c3)nc(N3CCNCC3)c2c1		CHEMBL1215572	=	IC50	nM	15.0	CHEMBL3863	Homo sapiens	IC50	nM	15.0
	3407909	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1ccc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)nc2c1		CHEMBL1215573	=	IC50	nM	43.0	CHEMBL3863	Homo sapiens	IC50	nM	43.0
	3407910	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1ccc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2c1		CHEMBL1215505	=	IC50	nM	356.0	CHEMBL3863	Homo sapiens	IC50	nM	356.0
	3407911	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cnc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2c1		CHEMBL1215570	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	nM	10000.0
	3407912	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cc2cc(-c3ccnc(NC4CCCCC4)c3)nc(N3CCNCC3)c2cn1		CHEMBL1215571	=	IC50	nM	1558.0	CHEMBL3863	Homo sapiens	IC50	nM	1558.0
	3407913	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cnc2cc(-c3ccnc(NC4CCCCC4)c3)nc(N3CCNCC3)c2c1		CHEMBL1215572	=	IC50	nM	262.0	CHEMBL3863	Homo sapiens	IC50	nM	262.0
	3407914	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1ccc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)nc2c1		CHEMBL1215573	=	IC50	nM	1521.0	CHEMBL3863	Homo sapiens	IC50	nM	1521.0
	3407915	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	C[C@H]1CN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)C[C@@H](C)N1		CHEMBL1215640	=	IC50	nM	3.0	CHEMBL3863	Homo sapiens	IC50	nM	3.0
	3407916	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CN1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215641	=	IC50	nM	2.0	CHEMBL3863	Homo sapiens	IC50	nM	2.0
	3407917	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CC(C)CN1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215642	=	IC50	nM	6.0	CHEMBL3863	Homo sapiens	IC50	nM	6.0
	3407918	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc2c(N3CCN(CC4CC4)CC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1215643	=	IC50	nM	2.0	CHEMBL3863	Homo sapiens	IC50	nM	2.0
	3407919	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc2c(N3CCN(C4CC4)CC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1215709	=	IC50	nM	13.0	CHEMBL3863	Homo sapiens	IC50	nM	13.0
	3407920	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	NCC1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215710	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3407921	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCOCC4)c3)cc2cn1		CHEMBL1215711	=	IC50	nM	0.4	CHEMBL3863	Homo sapiens	IC50	nM	0.4
	3407922	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CC(C)CN1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1215712	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3407923	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	C[C@H]1CN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)C[C@@H](C)N1		CHEMBL1215640	=	IC50	nM	30.0	CHEMBL3863	Homo sapiens	IC50	nM	30.0
	3407924	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CN1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215641	=	IC50	nM	206.0	CHEMBL3863	Homo sapiens	IC50	nM	206.0
	3407925	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CC(C)CN1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215642	=	IC50	nM	299.0	CHEMBL3863	Homo sapiens	IC50	nM	299.0
	3407926	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cc2c(N3CCN(CC4CC4)CC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1215643	=	IC50	nM	221.0	CHEMBL3863	Homo sapiens	IC50	nM	221.0
	3407927	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cc2c(N3CCN(C4CC4)CC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1215709	=	IC50	nM	454.0	CHEMBL3863	Homo sapiens	IC50	nM	454.0
	3407928	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	NCC1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215710	=	IC50	nM	49.0	CHEMBL3863	Homo sapiens	IC50	nM	49.0
	3407929	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCOCC4)c3)cc2cn1		CHEMBL1215711	=	IC50	nM	10.0	CHEMBL3863	Homo sapiens	IC50	nM	10.0
	3408958	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CC(C)CN1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1215712	=	IC50	nM	78.0	CHEMBL3863	Homo sapiens	IC50	nM	78.0
Active	3408959	CHEMBL1219828	Inhibition of PKD1 autophosphorylation at 100 nM	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	3408962	CHEMBL1219830	Inhibition of PKD1 assessed as phosphorylation of GFP-tagged HDAC5 at 1000 nM	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	3408963	CHEMBL1219830	Inhibition of PKD1 assessed as phosphorylation of GFP-tagged HDAC5 at 1000 nM	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	3408966	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	OCCNc1nc(-c2ccnc(NC3CCCCC3)c2)cc2cnccc12		CHEMBL1215792	=	IC50	nM	382.0	CHEMBL3863	Homo sapiens	IC50	nM	382.0
	3408967	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	OC1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215793	=	IC50	nM	15.0	CHEMBL3863	Homo sapiens	IC50	nM	15.0
	3408968	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	O=C1CN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CCN1		CHEMBL1215794	=	IC50	nM	4931.0	CHEMBL3863	Homo sapiens	IC50	nM	4931.0
	3408969	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CC(=O)C1CN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CCN1		CHEMBL1215795	=	IC50	nM	19.0	CHEMBL3863	Homo sapiens	IC50	nM	19.0
	3408970	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214709	=	IC50	nM	83.0	CHEMBL3863	Homo sapiens	IC50	nM	83.0
	3408971	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CNC(=O)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214710	=	IC50	nM	3.0	CHEMBL3863	Homo sapiens	IC50	nM	3.0
	3408972	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	O=C(NC1CCNCC1)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214711	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3408973	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	O=C(NCCN1CCCC1)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214712	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3408974	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	O=C(C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1)N1CCC(O)CC1		CHEMBL1214786	=	IC50	nM	4.0	CHEMBL3863	Homo sapiens	IC50	nM	4.0
	3408975	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	NCC(=O)N1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214787	=	IC50	nM	5.0	CHEMBL3863	Homo sapiens	IC50	nM	5.0
	3408976	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214788	=	IC50	nM	2.0	CHEMBL3863	Homo sapiens	IC50	nM	2.0
	3408977	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CCNC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214789	=	IC50	nM	3.0	CHEMBL3863	Homo sapiens	IC50	nM	3.0
	3408978	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	IC50	nM	3.0	CHEMBL3863	Homo sapiens	IC50	nM	3.0
	3408979	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	CC(C)CNC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214858	=	IC50	nM	2.0	CHEMBL3863	Homo sapiens	IC50	nM	2.0
	3408980	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	O=C(NCCO)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214859	=	IC50	nM	2.0	CHEMBL3863	Homo sapiens	IC50	nM	2.0
	3408981	CHEMBL1219826	Inhibition of PKD1 by TR-FRET assay	B	O=C(NCCN1CCCC1)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214860	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3408982	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	OCCNc1nc(-c2ccnc(NC3CCCCC3)c2)cc2cnccc12		CHEMBL1215792	>	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	nM	1000.0
	3408983	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	OC1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1215793	=	IC50	nM	474.0	CHEMBL3863	Homo sapiens	IC50	nM	474.0
	3408984	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	O=C1CN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CCN1		CHEMBL1215794	>	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	nM	1000.0
	3408985	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CC(=O)C1CN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CCN1		CHEMBL1215795	>	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	nM	1000.0
	3408986	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214709	=	IC50	nM	204.0	CHEMBL3863	Homo sapiens	IC50	nM	204.0
	3408987	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CNC(=O)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214710	=	IC50	nM	94.0	CHEMBL3863	Homo sapiens	IC50	nM	94.0
	3408988	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	O=C(NC1CCNCC1)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214711	=	IC50	nM	44.0	CHEMBL3863	Homo sapiens	IC50	nM	44.0
	3408989	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	O=C(NCCN1CCCC1)C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1		CHEMBL1214712	=	IC50	nM	35.0	CHEMBL3863	Homo sapiens	IC50	nM	35.0
	3408990	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	O=C(C1CCN(c2nc(-c3ccnc(NC4CCCCC4)c3)cc3cnccc23)CC1)N1CCC(O)CC1		CHEMBL1214786	=	IC50	nM	294.0	CHEMBL3863	Homo sapiens	IC50	nM	294.0
	3408991	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	NCC(=O)N1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214787	=	IC50	nM	749.0	CHEMBL3863	Homo sapiens	IC50	nM	749.0
	3408992	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214788	=	IC50	nM	20.0	CHEMBL3863	Homo sapiens	IC50	nM	20.0
	3408993	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CCNC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214789	=	IC50	nM	83.0	CHEMBL3863	Homo sapiens	IC50	nM	83.0
	3408994	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	IC50	nM	391.0	CHEMBL3863	Homo sapiens	IC50	nM	391.0
	3408995	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	CC(C)CNC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214858	=	IC50	nM	228.0	CHEMBL3863	Homo sapiens	IC50	nM	228.0
	3408996	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	O=C(NCCO)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214859	=	IC50	nM	60.0	CHEMBL3863	Homo sapiens	IC50	nM	60.0
	3408997	CHEMBL1219827	Inhibition of PKD1 assessed as HDAC5 neuclear export	B	O=C(NCCN1CCCC1)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214860	=	IC50	nM	96.0	CHEMBL3863	Homo sapiens	IC50	nM	96.0
	3409064	CHEMBL1219868	Inhibition of PKD1 assessed as residual activity at 1 uM by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Activity	%	2.0	CHEMBL3863	Homo sapiens	Activity	%	2.0
	3409065	CHEMBL1219868	Inhibition of PKD1 assessed as residual activity at 1 uM by TR-FRET assay	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	Activity	%	3.0	CHEMBL3863	Homo sapiens	Activity	%	3.0
	3409066	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	O=C1NCc2c1cc(-c1ccnc(NC3CCCCC3)c1)nc2N1CCNCC1		CHEMBL1215362	=	IC50	nM	35.0	CHEMBL3863	Homo sapiens	IC50	nM	35.0
	3409067	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	O=C1NCc2c1cc(N1CCNCC1)nc2-c1ccnc(NC2CCCCC2)c1		CHEMBL1215363	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409068	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	IC50	nM	0.6	CHEMBL3863	Homo sapiens	IC50	nM	0.6
	3409069	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	IC50	nM	32.0	CHEMBL3863	Homo sapiens	IC50	nM	32.0
	3409071	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409072	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3)c2)nc(N2CCNCC2)c1		CHEMBL1215000	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409073	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCOCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215001	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409074	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	CC(C)Nc1cc(-c2cc(C(N)=O)cc(N3CCNCC3)n2)ccn1		CHEMBL1215002	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409075	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	Cn1ccc(Nc2cc(-c3cc(C(N)=O)cc(N4CCNCC4)n3)ccn2)n1		CHEMBL1215074	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409076	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3Cl)c2)nc(N2CCNCC2)c1		CHEMBL1215075	=	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409077	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215076	=	IC50	nM	6.0	CHEMBL3863	Homo sapiens	IC50	nM	6.0
	3409078	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	CCNc1cc(-c2cc(C(N)=O)cc(N3CCNCC3)n2)ccn1		CHEMBL1215077	=	IC50	nM	4.0	CHEMBL3863	Homo sapiens	IC50	nM	4.0
	3409079	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	N#Cc1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215078	=	IC50	nM	18.0	CHEMBL3863	Homo sapiens	IC50	nM	18.0
	3409080	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	N#Cc1cc(-c2ccnc(Nc3ccccc3)c2)nc(N2CCNCC2)c1		CHEMBL1215149	=	IC50	nM	5.0	CHEMBL3863	Homo sapiens	IC50	nM	5.0
	3409081	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	Cn1ccc(Nc2cc(-c3cc(C#N)cc(N4CCNCC4)n3)ccn2)n1		CHEMBL1215150	=	IC50	nM	8.0	CHEMBL3863	Homo sapiens	IC50	nM	8.0
	3409082	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	c1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)cc(NC2CCCCC2)n1		CHEMBL1215151	<	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409083	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	c1cc(-c2cc(-c3cc[nH]n3)cc(N3CCNCC3)n2)cc(NC2CCCCC2)n1		CHEMBL1215152	=	IC50	nM	4.0	CHEMBL3863	Homo sapiens	IC50	nM	4.0
	3409084	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	CC(C)Nc1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)ccn1		CHEMBL1215153	<	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409085	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	c1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)cc(NC2CCOCC2)n1		CHEMBL1215219	<	IC50	nM	1.0	CHEMBL3863	Homo sapiens	IC50	nM	1.0
	3409086	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(N[C@@H]2CCNC2)nc(-c2ccnc(NC3CCCCC3)c2)c1		CHEMBL1215220	=	IC50	nM	2.0	CHEMBL3863	Homo sapiens	IC50	nM	2.0
	3409087	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(N[C@H]2CCNC2)nc(-c2ccnc(NC3CCCCC3)c2)c1		CHEMBL1215221	=	IC50	nM	68.0	CHEMBL3863	Homo sapiens	IC50	nM	68.0
	3409088	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	C[C@@H]1CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215222	=	IC50	nM	6.0	CHEMBL3863	Homo sapiens	IC50	nM	6.0
	3409089	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	C[C@H]1CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215223	=	IC50	nM	8.0	CHEMBL3863	Homo sapiens	IC50	nM	8.0
	3409090	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCCC(N)C2)c1		CHEMBL1215285	=	IC50	nM	14.0	CHEMBL3863	Homo sapiens	IC50	nM	14.0
	3409091	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	CN1CCN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CC1		CHEMBL1215286	=	IC50	nM	25.0	CHEMBL3863	Homo sapiens	IC50	nM	25.0
	3409092	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NCC1CCN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CC1		CHEMBL1215287	=	IC50	nM	46.0	CHEMBL3863	Homo sapiens	IC50	nM	46.0
	3409093	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	CC1(C)CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215288	=	IC50	nM	55.0	CHEMBL3863	Homo sapiens	IC50	nM	55.0
	3409094	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCOCC2)c1		CHEMBL1215289	>	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	nM	1000.0
	3409095	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	FC(F)(F)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215360	=	IC50	nM	20.0	CHEMBL3863	Homo sapiens	IC50	nM	20.0
	3409096	CHEMBL1219870	Inhibition of PKD1 by TR-FRET assay	B	FC(F)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215361	=	IC50	nM	17.0	CHEMBL3863	Homo sapiens	IC50	nM	17.0
	3409122	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999	=	EC50	nM	77.0	CHEMBL3863	Homo sapiens	EC50	nM	77.0
	3409123	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3)c2)nc(N2CCNCC2)c1		CHEMBL1215000	=	EC50	nM	24.0	CHEMBL3863	Homo sapiens	EC50	nM	24.0
	3409124	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(-c2ccnc(NC3CCOCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215001	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409125	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	CC(C)Nc1cc(-c2cc(C(N)=O)cc(N3CCNCC3)n2)ccn1		CHEMBL1215002	=	EC50	nM	438.0	CHEMBL3863	Homo sapiens	EC50	nM	438.0
	3409126	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	Cn1ccc(Nc2cc(-c3cc(C(N)=O)cc(N4CCNCC4)n3)ccn2)n1		CHEMBL1215074	=	EC50	nM	674.0	CHEMBL3863	Homo sapiens	EC50	nM	674.0
	3409127	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3Cl)c2)nc(N2CCNCC2)c1		CHEMBL1215075	=	EC50	nM	478.0	CHEMBL3863	Homo sapiens	EC50	nM	478.0
	3409128	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(-c2ccnc(NC3CCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215076	=	EC50	nM	202.0	CHEMBL3863	Homo sapiens	EC50	nM	202.0
	3409129	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	CCNc1cc(-c2cc(C(N)=O)cc(N3CCNCC3)n2)ccn1		CHEMBL1215077	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409130	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	N#Cc1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215078	=	EC50	nM	66.0	CHEMBL3863	Homo sapiens	EC50	nM	66.0
	3409131	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	N#Cc1cc(-c2ccnc(Nc3ccccc3)c2)nc(N2CCNCC2)c1		CHEMBL1215149	=	EC50	nM	378.0	CHEMBL3863	Homo sapiens	EC50	nM	378.0
	3409132	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	Cn1ccc(Nc2cc(-c3cc(C#N)cc(N4CCNCC4)n3)ccn2)n1		CHEMBL1215150	=	EC50	nM	428.0	CHEMBL3863	Homo sapiens	EC50	nM	428.0
	3409133	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	c1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)cc(NC2CCCCC2)n1		CHEMBL1215151	=	EC50	nM	17.0	CHEMBL3863	Homo sapiens	EC50	nM	17.0
	3409134	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	c1cc(-c2cc(-c3cc[nH]n3)cc(N3CCNCC3)n2)cc(NC2CCCCC2)n1		CHEMBL1215152	=	EC50	nM	704.0	CHEMBL3863	Homo sapiens	EC50	nM	704.0
	3409135	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	CC(C)Nc1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)ccn1		CHEMBL1215153	=	EC50	nM	92.0	CHEMBL3863	Homo sapiens	EC50	nM	92.0
	3409136	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	c1cc(-c2cc(-c3cn[nH]c3)cc(N3CCNCC3)n2)cc(NC2CCOCC2)n1		CHEMBL1215219	=	EC50	nM	234.0	CHEMBL3863	Homo sapiens	EC50	nM	234.0
	3409137	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(N[C@@H]2CCNC2)nc(-c2ccnc(NC3CCCCC3)c2)c1		CHEMBL1215220	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409138	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(N[C@H]2CCNC2)nc(-c2ccnc(NC3CCCCC3)c2)c1		CHEMBL1215221	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409139	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	C[C@@H]1CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215222	=	EC50	nM	679.0	CHEMBL3863	Homo sapiens	EC50	nM	679.0
	3409140	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	C[C@H]1CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215223	=	EC50	nM	831.0	CHEMBL3863	Homo sapiens	EC50	nM	831.0
	3409141	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCCC(N)C2)c1		CHEMBL1215285	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409142	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	CN1CCN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CC1		CHEMBL1215286	=	EC50	nM	752.0	CHEMBL3863	Homo sapiens	EC50	nM	752.0
	3409143	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	NCC1CCN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CC1		CHEMBL1215287	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409144	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	CC1(C)CN(c2cc(C(N)=O)cc(-c3ccnc(NC4CCCCC4)c3)n2)CCN1		CHEMBL1215288	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3409145	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	FC(F)(F)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215360	=	EC50	nM	342.0	CHEMBL3863	Homo sapiens	EC50	nM	342.0
	3409146	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	FC(F)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1215361	=	EC50	nM	568.0	CHEMBL3863	Homo sapiens	EC50	nM	568.0
Active	3409194	CHEMBL1219872	Inhibition of PKD1 autophosphorylation at 1 uM	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	3409209	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	O=C1NCc2c1cc(N1CCNCC1)nc2-c1ccnc(NC2CCCCC2)c1		CHEMBL1215363	=	EC50	nM	115.0	CHEMBL3863	Homo sapiens	EC50	nM	115.0
	3409210	CHEMBL1219871	Inhibition of PKD1 assessed as inhibition of HDAC5 neuclear export	B	O=C1NCc2c1cc(-c1ccnc(NC3CCCCC3)c1)nc2N1CCNCC1		CHEMBL1215362	>	EC50	nM	1000.0	CHEMBL3863	Homo sapiens	EC50	nM	1000.0
	3443501	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	19.0	CHEMBL3863	Homo sapiens	INH	%	19.0
	3443718	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	73.0	CHEMBL3863	Homo sapiens	INH	%	73.0
	3444873	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	70.0	CHEMBL3863	Homo sapiens	INH	%	70.0
	3445268	CHEMBL1244940	Binding affinity to PRKD1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14.0	CHEMBL3863	Homo sapiens	Kd	nM	14.0
	3445497	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	15.0	CHEMBL3863	Homo sapiens	INH	%	15.0
	3445714	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	5.0	CHEMBL3863	Homo sapiens	INH	%	5.0
	3445909	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	25.0	CHEMBL3863	Homo sapiens	INH	%	25.0
	3446099	CHEMBL1244267	Inhibition of PKCmu at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	61.0	CHEMBL3863	Homo sapiens	INH	%	61.0
	3448587	CHEMBL1244940	Binding affinity to PRKD1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	3449311	CHEMBL1244940	Binding affinity to PRKD1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3863	Homo sapiens	Kd	nM	310.0
	3449818	CHEMBL1244940	Binding affinity to PRKD1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	3450212	CHEMBL1244940	Binding affinity to PRKD1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	3450855	CHEMBL1244940	Binding affinity to PRKD1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	3451124	CHEMBL1244940	Binding affinity to PRKD1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	uM	10.0
	3463334	CHEMBL1251594	Inhibition of PRKD1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	97.0	CHEMBL3863	Homo sapiens	INH	%	97.0
	3463878	CHEMBL1251594	Inhibition of PRKD1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	5.0	CHEMBL3863	Homo sapiens	INH	%	5.0
	3464097	CHEMBL1251594	Inhibition of PRKD1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	71.0	CHEMBL3863	Homo sapiens	INH	%	71.0
	5120361	CHEMBL1648685	Inhibition of human PKCmu at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	104.0	CHEMBL3863	Homo sapiens	INH	%	104.0
	5133707	CHEMBL1648705	Inhibition of PKDl assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	79.0	CHEMBL3863	Homo sapiens	Activity	%	79.0
	5133802	CHEMBL1648705	Inhibition of PKDl assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	5133869	CHEMBL1648705	Inhibition of PKDl assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	83.0	CHEMBL3863	Homo sapiens	Activity	%	83.0
	5191371	CHEMBL1664042	Inhibition of PKD1 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	20.0	CHEMBL3863	Homo sapiens	INH	%	20.0
	5191372	CHEMBL1664042	Inhibition of PKD1 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	79.0	CHEMBL3863	Homo sapiens	INH	%	79.0
	5197197	CHEMBL1670497	Inhibition of human PKCmu by RFBA assay	B	O=c1[nH]ccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1667967	=	IC50	nM	501.19	CHEMBL3863	Homo sapiens	pIC50		6.3
	5197203	CHEMBL1670497	Inhibition of human PKCmu by RFBA assay	B	Nc1nccc2c(S(=O)(=O)N3CCCNCC3)cccc12		CHEMBL1667963	=	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	pIC50		5.0
	5209150	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	O=C1NCCCc2c1oc1ccc(O)cc21		CHEMBL1450770	=	IC50	nM	182.0	CHEMBL3863	Homo sapiens	IC50	nM	182.0
	5209151	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	O=C1NCCCc2c1[nH]c1ccc(O)cc21		CHEMBL1672570	=	IC50	nM	130.0	CHEMBL3863	Homo sapiens	IC50	nM	130.0
	5209152	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	O=C1NCCSc2c1sc1ccc(O)cc21		CHEMBL1672571	=	IC50	nM	28.3	CHEMBL3863	Homo sapiens	IC50	nM	28.3
	5209153	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	COc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL319170	=	IC50	nM	82.5	CHEMBL3863	Homo sapiens	IC50	nM	82.5
	5209154	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	[N-]=[N+]=Nc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL1672572	=	IC50	nM	74.9	CHEMBL3863	Homo sapiens	IC50	nM	74.9
	5209155	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	O=C1NCCCSc2c1sc1ccc(O)cc21		CHEMBL1672573	=	IC50	nM	111.0	CHEMBL3863	Homo sapiens	IC50	nM	111.0
	5209156	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	COc1ccc2sc3c(c2c1)SCCCNC3=O		CHEMBL1672574	=	IC50	nM	193.0	CHEMBL3863	Homo sapiens	IC50	nM	193.0
	5220286	CHEMBL1681586	Inhibition of human recombinant PKD1 after 10 mins by radiometric assay	B	COc1ncc2sc3c(c2n1)SCCNC3=O		CHEMBL1672575	=	IC50	nM	124.0	CHEMBL3863	Homo sapiens	IC50	nM	124.0
	5220287	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	O=C1NCCCc2c1oc1ccc(O)cc21		CHEMBL1450770	=	IC50	nM	11800.0	CHEMBL3863	Homo sapiens	IC50	uM	11.8
	5220288	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	O=C1NCCCc2c1[nH]c1ccc(O)cc21		CHEMBL1672570	>	IC50	nM	50000.0	CHEMBL3863	Homo sapiens	IC50	uM	50.0
	5220289	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	O=C1NCCSc2c1sc1ccc(O)cc21		CHEMBL1672571	=	IC50	nM	2200.0	CHEMBL3863	Homo sapiens	IC50	uM	2.2
	5220290	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	COc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL319170	=	IC50	nM	3100.0	CHEMBL3863	Homo sapiens	IC50	uM	3.1
	5220291	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	[N-]=[N+]=Nc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL1672572	=	IC50	nM	2200.0	CHEMBL3863	Homo sapiens	IC50	uM	2.2
	5220292	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	O=C1NCCCSc2c1sc1ccc(O)cc21		CHEMBL1672573	=	IC50	nM	2600.0	CHEMBL3863	Homo sapiens	IC50	uM	2.6
	5220293	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	COc1ccc2sc3c(c2c1)SCCCNC3=O		CHEMBL1672574	=	IC50	nM	18600.0	CHEMBL3863	Homo sapiens	IC50	uM	18.6
	5220294	CHEMBL1681587	Inhibition of PKD1 autophosphorylation at Ser916 in human PMA-induced LNCAP cells by Western blotting	B	COc1ncc2sc3c(c2n1)SCCNC3=O		CHEMBL1672575	=	IC50	nM	6800.0	CHEMBL3863	Homo sapiens	IC50	uM	6.8
	5223298	CHEMBL1679288	Binding affinity to PKD1 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL3863	Homo sapiens	INH	%	90.0
	5235467	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CCCNC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1683310	=	IC50	nM	2500.0	CHEMBL3863	Homo sapiens	IC50	uM	2.5
	5235468	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1683313	=	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	uM	1.0
	5235469	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)c(Br)c3)[nH]n2)c1		CHEMBL1683314	=	IC50	nM	280.0	CHEMBL3863	Homo sapiens	IC50	uM	0.28
	5235470	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)c(-c4ccccc4)c3)[nH]n2)c1		CHEMBL1683315	=	IC50	nM	980.0	CHEMBL3863	Homo sapiens	IC50	uM	0.98
	5235471	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)c(-c4ccncc4)c3)[nH]n2)c1		CHEMBL1683422	=	IC50	nM	200.0	CHEMBL3863	Homo sapiens	IC50	uM	0.2
	5235472	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCC#N)c4)n[nH]3)cc2)CC1		CHEMBL1683423	=	IC50	nM	140.0	CHEMBL3863	Homo sapiens	IC50	uM	0.14
	5235473	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCC#N)c4)n[nH]3)cc2Br)CC1		CHEMBL1683424	=	IC50	nM	87.0	CHEMBL3863	Homo sapiens	IC50	uM	0.087
	5235474	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCCC#N)c4)n[nH]3)cc2)CC1		CHEMBL1683425	=	IC50	nM	750.0	CHEMBL3863	Homo sapiens	IC50	uM	0.75
	5235475	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	COCCNC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1683426	=	IC50	nM	6900.0	CHEMBL3863	Homo sapiens	IC50	uM	6.9
	5235476	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCCO)c4)n[nH]3)cc2)CC1		CHEMBL1683427	=	IC50	nM	1600.0	CHEMBL3863	Homo sapiens	IC50	uM	1.6
	5235477	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN(C)CCNC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1683428	=	IC50	nM	2000.0	CHEMBL3863	Homo sapiens	IC50	uM	2.0
	5235478	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCC(F)(F)F)c4)n[nH]3)cc2)CC1		CHEMBL1683429	=	IC50	nM	1100.0	CHEMBL3863	Homo sapiens	IC50	uM	1.1
	5235479	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCC#N)c4)no3)cc2)CC1		CHEMBL1683430	=	IC50	nM	200.0	CHEMBL3863	Homo sapiens	IC50	uM	0.2
	5235480	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)on2)c1		CHEMBL1683431	=	IC50	nM	60.0	CHEMBL3863	Homo sapiens	IC50	uM	0.06
	5235481	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	C[C@@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)on2)c1		CHEMBL1683432	=	IC50	nM	430.0	CHEMBL3863	Homo sapiens	IC50	uM	0.43
	5235482	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NCc1ccc(-c2cc(-c3cccc(C(=O)NC(C)C)c3)n[nH]2)cc1		CHEMBL1683433	=	IC50	nM	100.0	CHEMBL3863	Homo sapiens	IC50	uM	0.1
	5235483	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	COCCNCc1ccc(-c2cc(-c3cccc(C(=O)NC(C)C)c3)n[nH]2)cc1		CHEMBL1683311	=	IC50	nM	430.0	CHEMBL3863	Homo sapiens	IC50	uM	0.43
	5235484	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CC4)cc3)[nH]n2)c1		CHEMBL1683312	=	IC50	nM	390.0	CHEMBL3863	Homo sapiens	IC50	uM	0.39
	5235485	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(CNCC(F)(F)F)cc3)[nH]n2)c1		CHEMBL1683434	=	IC50	nM	6000.0	CHEMBL3863	Homo sapiens	IC50	uM	6.0
	5235486	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NCc1ccc(-c2cc(-c3cccc(C(=O)N[C@H](C)C#N)c3)n[nH]2)cc1		CHEMBL1683435	=	IC50	nM	3.7	CHEMBL3863	Homo sapiens	IC50	uM	0.0037
	5235487	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NCc1ccc(-c2cc(-c3cccc(C(=O)N[C@H](C)C#N)c3)no2)cc1		CHEMBL1683436	=	IC50	nM	9.0	CHEMBL3863	Homo sapiens	IC50	uM	0.009
	5235488	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683437	=	IC50	nM	220.0	CHEMBL3863	Homo sapiens	IC50	uM	0.22
	5235489	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	N#CCNC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683438	=	IC50	nM	19.0	CHEMBL3863	Homo sapiens	IC50	uM	0.019
	5235490	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(C)(C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683439	=	IC50	nM	49.0	CHEMBL3863	Homo sapiens	IC50	uM	0.049
	5235491	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	=	IC50	nM	5.5	CHEMBL3863	Homo sapiens	IC50	uM	0.0055
	5235492	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	C[C@@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683441	=	IC50	nM	95.0	CHEMBL3863	Homo sapiens	IC50	uM	0.095
	5236035	CHEMBL1686362	Inhibition of PKD1 in rat neonatal ventricular myocytes expressing GFP-HDAC5 assessed as inhibition of phosphorylation-dependent HDAC5 nuclear export	B	CN1CCN(c2ccc(-c3cc(-c4cccc(C(=O)NCC#N)c4)n[nH]3)cc2Br)CC1		CHEMBL1683424	=	EC50	nM	680.0	CHEMBL3863	Homo sapiens	EC50	uM	0.68
	5236036	CHEMBL1686362	Inhibition of PKD1 in rat neonatal ventricular myocytes expressing GFP-HDAC5 assessed as inhibition of phosphorylation-dependent HDAC5 nuclear export	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)on2)c1		CHEMBL1683431	=	EC50	nM	570.0	CHEMBL3863	Homo sapiens	EC50	uM	0.57
	5236037	CHEMBL1686362	Inhibition of PKD1 in rat neonatal ventricular myocytes expressing GFP-HDAC5 assessed as inhibition of phosphorylation-dependent HDAC5 nuclear export	B	CC(C)NCc1ccc(-c2cc(-c3cccc(C(=O)N[C@H](C)C#N)c3)n[nH]2)cc1		CHEMBL1683435	=	EC50	nM	530.0	CHEMBL3863	Homo sapiens	EC50	uM	0.53
	5236038	CHEMBL1686362	Inhibition of PKD1 in rat neonatal ventricular myocytes expressing GFP-HDAC5 assessed as inhibition of phosphorylation-dependent HDAC5 nuclear export	B	CC(C)NCc1ccc(-c2cc(-c3cccc(C(=O)N[C@H](C)C#N)c3)no2)cc1		CHEMBL1683436	=	EC50	nM	460.0	CHEMBL3863	Homo sapiens	EC50	uM	0.46
	5236039	CHEMBL1686362	Inhibition of PKD1 in rat neonatal ventricular myocytes expressing GFP-HDAC5 assessed as inhibition of phosphorylation-dependent HDAC5 nuclear export	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	=	EC50	nM	240.0	CHEMBL3863	Homo sapiens	EC50	uM	0.24
	5236045	CHEMBL1686343	Inhibition of human PKD1 by TR-FRET assay	B	CC(=O)Nc1cccc(-c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1683442	=	IC50	nM	2300.0	CHEMBL3863	Homo sapiens	IC50	uM	2.3
	6274430	CHEMBL1806021	Inhibition of PKD1 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	6341118	CHEMBL1826690	Activity of PRKD1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	6352268	CHEMBL1826245	Inhibition of PKD1 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	67.0	CHEMBL3863	Homo sapiens	Activity	%	67.0
	6385558	CHEMBL1837945	Inhibition of human PKD1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL3863	Homo sapiens	INH	%	35.0
	6385559	CHEMBL1837945	Inhibition of human PKD1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL3863	Homo sapiens	INH	%	35.0
	6385560	CHEMBL1837945	Inhibition of human PKD1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL3863	Homo sapiens	INH	%	35.0
	6385561	CHEMBL1837945	Inhibition of human PKD1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL3863	Homo sapiens	INH	%	35.0
	6385562	CHEMBL1837945	Inhibition of human PKD1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL3863	Homo sapiens	INH	%	35.0
	7567279	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7567738	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7568209	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7568667	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2400.0	CHEMBL3863	Homo sapiens	Kd	nM	2400.0
	7569252	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7569712	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	990.0	CHEMBL3863	Homo sapiens	Kd	nM	990.0
	7570205	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7570632	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3863	Homo sapiens	Kd	nM	310.0
	7571228	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	320.0	CHEMBL3863	Homo sapiens	Kd	nM	320.0
	7571685	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7571719	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7572182	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7572598	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	80.0	CHEMBL3863	Homo sapiens	Kd	nM	80.0
	7573209	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	990.0	CHEMBL3863	Homo sapiens	Kd	nM	990.0
	7573700	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	420.0	CHEMBL3863	Homo sapiens	Kd	nM	420.0
	7574169	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7574577	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7575206	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7575677	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7576142	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7576550	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7576719	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7577178	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7577656	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1200.0	CHEMBL3863	Homo sapiens	Kd	nM	1200.0
	7578126	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7578531	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7578727	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7579101	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7579551	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	520.0	CHEMBL3863	Homo sapiens	Kd	nM	520.0
	7580025	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7580494	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7580897	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7581085	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7581470	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	4600.0	CHEMBL3863	Homo sapiens	Kd	nM	4600.0
	7581915	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7582386	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7583431	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7583828	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1200.0	CHEMBL3863	Homo sapiens	Kd	nM	1200.0
	7584273	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7584764	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7585168	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7585761	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7586169	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7586615	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	3500.0	CHEMBL3863	Homo sapiens	Kd	nM	3500.0
	7586644	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7587098	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7587722	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7588141	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14.0	CHEMBL3863	Homo sapiens	Kd	nM	14.0
	7588623	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7589074	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7589687	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7590136	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	650.0	CHEMBL3863	Homo sapiens	Kd	nM	650.0
	7590610	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7591061	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7591640	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7592112	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7592585	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7593038	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7593185	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1200.0	CHEMBL3863	Homo sapiens	Kd	nM	1200.0
	7593620	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7594092	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	3500.0	CHEMBL3863	Homo sapiens	Kd	nM	3500.0
	7594565	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7595017	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7595153	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7595597	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7596071	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7596542	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7596989	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	27.0	CHEMBL3863	Homo sapiens	Kd	nM	27.0
	7597125	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7597578	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7598051	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	820.0	CHEMBL3863	Homo sapiens	Kd	nM	820.0
	7598521	CHEMBL1908581	Binding constant for PRKD1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3863	Homo sapiens	Kd	nM	10000.0
	7961123	CHEMBL1931543	Inhibition of PKCmu	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3863	Homo sapiens	IC50	uM	30.0
	7961124	CHEMBL1931543	Inhibition of PKCmu	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL3863	Homo sapiens	IC50	uM	30.0
	7969786	CHEMBL1929887	Inhibition of PKD1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	63.0	CHEMBL3863	Homo sapiens	Activity	%	63.0
	7989287	CHEMBL1936690	Inhibition of human PRKD1 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	7989288	CHEMBL1936690	Inhibition of human PRKD1 at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	7989289	CHEMBL1936690	Inhibition of human PRKD1 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	>=	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	7989290	CHEMBL1936690	Inhibition of human PRKD1 at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	7989382	CHEMBL1937076	Inhibition of human PRKD1	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	35.0	CHEMBL3863	Homo sapiens	IC50	nM	35.0
	8018864	CHEMBL1948960	Inhibition of PDK1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	91.0	CHEMBL3863	Homo sapiens	Activity	%	91.0
	8018865	CHEMBL1948960	Inhibition of PDK1 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	8018866	CHEMBL1948960	Inhibition of PDK1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	65.0	CHEMBL3863	Homo sapiens	Activity	%	65.0
	8061237	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.78	CHEMBL3863	Homo sapiens	Inhibition	%	0.78
	8061414	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.69	CHEMBL3863	Homo sapiens	Inhibition	%	-1.69
	8061638	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.22	CHEMBL3863	Homo sapiens	Inhibition	%	2.22
	8061745	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	39.63	CHEMBL3863	Homo sapiens	Inhibition	%	39.63
	8061936	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.63	CHEMBL3863	Homo sapiens	Inhibition	%	2.63
	8062160	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	10.61	CHEMBL3863	Homo sapiens	Inhibition	%	10.61
	8062276	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.06	CHEMBL3863	Homo sapiens	Inhibition	%	3.06
	8062662	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.12	CHEMBL3863	Homo sapiens	Inhibition	%	5.12
	8062760	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.26	CHEMBL3863	Homo sapiens	Inhibition	%	3.26
	8062984	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.32	CHEMBL3863	Homo sapiens	Inhibition	%	0.32
	8063116	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.64	CHEMBL3863	Homo sapiens	Inhibition	%	2.64
	8063507	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.95	CHEMBL3863	Homo sapiens	Inhibition	%	3.95
	8063615	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.47	CHEMBL3863	Homo sapiens	Inhibition	%	2.47
	8063839	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.43	CHEMBL3863	Homo sapiens	Inhibition	%	5.43
	8064021	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.4	CHEMBL3863	Homo sapiens	Inhibition	%	3.4
	8064136	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	14.85	CHEMBL3863	Homo sapiens	Inhibition	%	14.85
	8064360	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.61	CHEMBL3863	Homo sapiens	Inhibition	%	1.61
	8064570	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.71	CHEMBL3863	Homo sapiens	Inhibition	%	3.71
	8064708	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.41	CHEMBL3863	Homo sapiens	Inhibition	%	0.41
	8064932	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.5	CHEMBL3863	Homo sapiens	Inhibition	%	2.5
	8065098	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.32	CHEMBL3863	Homo sapiens	Inhibition	%	2.32
	8065438	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.15	CHEMBL3863	Homo sapiens	Inhibition	%	2.15
	8065613	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	33.59	CHEMBL3863	Homo sapiens	Inhibition	%	33.59
	8065952	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.29	CHEMBL3863	Homo sapiens	Inhibition	%	4.29
	8066162	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.12	CHEMBL3863	Homo sapiens	Inhibition	%	1.12
	8066522	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.77	CHEMBL3863	Homo sapiens	Inhibition	%	1.77
	8066688	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.39	CHEMBL3863	Homo sapiens	Inhibition	%	1.39
	8067036	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.31	CHEMBL3863	Homo sapiens	Inhibition	%	4.31
	8067211	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.33	CHEMBL3863	Homo sapiens	Inhibition	%	2.33
	8067556	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.78	CHEMBL3863	Homo sapiens	Inhibition	%	1.78
	8067766	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.3	CHEMBL3863	Homo sapiens	Inhibition	%	2.3
	8068125	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	16.37	CHEMBL3863	Homo sapiens	Inhibition	%	16.37
	8068289	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.32	CHEMBL3863	Homo sapiens	Inhibition	%	5.32
	8068638	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.57	CHEMBL3863	Homo sapiens	Inhibition	%	1.57
	8068812	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.18	CHEMBL3863	Homo sapiens	Inhibition	%	5.18
	8069036	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.99	CHEMBL3863	Homo sapiens	Inhibition	%	2.99
	8069161	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	6.49	CHEMBL3863	Homo sapiens	Inhibition	%	6.49
	8069456	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	23.22	CHEMBL3863	Homo sapiens	Inhibition	%	23.22
	8069617	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.44	CHEMBL3863	Homo sapiens	Inhibition	%	2.44
	8069841	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.49	CHEMBL3863	Homo sapiens	Inhibition	%	2.49
	8069967	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.87	CHEMBL3863	Homo sapiens	Inhibition	%	2.87
	8070363	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.01	CHEMBL3863	Homo sapiens	Inhibition	%	5.01
	8070488	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.12	CHEMBL3863	Homo sapiens	Inhibition	%	1.12
	8070712	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	8.61	CHEMBL3863	Homo sapiens	Inhibition	%	8.61
	8070786	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	79.43	CHEMBL3863	Homo sapiens	Inhibition	%	79.43
	8071167	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.15	CHEMBL3863	Homo sapiens	Inhibition	%	2.15
	8071293	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.77	CHEMBL3863	Homo sapiens	Inhibition	%	2.77
	8071517	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	32.8	CHEMBL3863	Homo sapiens	Inhibition	%	32.8
	8071690	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.8	CHEMBL3863	Homo sapiens	Inhibition	%	2.8
	8072039	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.06	CHEMBL3863	Homo sapiens	Inhibition	%	0.06
	8072129	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.22	CHEMBL3863	Homo sapiens	Inhibition	%	0.22
	8072353	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.03	CHEMBL3863	Homo sapiens	Inhibition	%	1.03
	8072510	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.86	CHEMBL3863	Homo sapiens	Inhibition	%	2.86
	8072859	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.6	CHEMBL3863	Homo sapiens	Inhibition	%	0.6
	8073026	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.78	CHEMBL3863	Homo sapiens	Inhibition	%	5.78
	8073375	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.84	CHEMBL3863	Homo sapiens	Inhibition	%	0.84
	8073494	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.96	CHEMBL3863	Homo sapiens	Inhibition	%	0.96
	8073718	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.76	CHEMBL3863	Homo sapiens	Inhibition	%	1.76
	8073951	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.55	CHEMBL3863	Homo sapiens	Inhibition	%	1.55
	8074103	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.15	CHEMBL3863	Homo sapiens	Inhibition	%	3.15
	8074457	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.47	CHEMBL3863	Homo sapiens	Inhibition	%	1.47
	8074614	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.86	CHEMBL3863	Homo sapiens	Inhibition	%	4.86
	8074838	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	8.87	CHEMBL3863	Homo sapiens	Inhibition	%	8.87
	8074965	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.17	CHEMBL3863	Homo sapiens	Inhibition	%	-0.17
	8075300	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.04	CHEMBL3863	Homo sapiens	Inhibition	%	1.04
	8075537	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.93	CHEMBL3863	Homo sapiens	Inhibition	%	5.93
	8075678	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.5	CHEMBL3863	Homo sapiens	Inhibition	%	2.5
	8075902	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.42	CHEMBL3863	Homo sapiens	Inhibition	%	3.42
	8076044	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.46	CHEMBL3863	Homo sapiens	Inhibition	%	-0.46
	8076416	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.65	CHEMBL3863	Homo sapiens	Inhibition	%	2.65
	8076550	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.6	CHEMBL3863	Homo sapiens	Inhibition	%	3.6
	8076876	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.24	CHEMBL3863	Homo sapiens	Inhibition	%	2.24
	8077123	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	8.23	CHEMBL3863	Homo sapiens	Inhibition	%	8.23
	8077475	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.29	CHEMBL3863	Homo sapiens	Inhibition	%	4.29
	8077626	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.62	CHEMBL3863	Homo sapiens	Inhibition	%	0.62
	8077993	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	5.06	CHEMBL3863	Homo sapiens	Inhibition	%	5.06
	8078132	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.96	CHEMBL3863	Homo sapiens	Inhibition	%	-1.96
	8078356	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	4.59	CHEMBL3863	Homo sapiens	Inhibition	%	4.59
	8078458	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.36	CHEMBL3863	Homo sapiens	Inhibition	%	0.36
	8078708	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	61.64	CHEMBL3863	Homo sapiens	Inhibition	%	61.64
	8079048	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.48	CHEMBL3863	Homo sapiens	Inhibition	%	4.48
	8079206	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.17	CHEMBL3863	Homo sapiens	Inhibition	%	-1.17
	8079430	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.36	CHEMBL3863	Homo sapiens	Inhibition	%	0.36
	8079572	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.32	CHEMBL3863	Homo sapiens	Inhibition	%	2.32
	8079935	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	21.52	CHEMBL3863	Homo sapiens	Inhibition	%	21.52
	8080040	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	5.6	CHEMBL3863	Homo sapiens	Inhibition	%	5.6
	8080264	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.15	CHEMBL3863	Homo sapiens	Inhibition	%	0.15
	8080292	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.18	CHEMBL3863	Homo sapiens	Inhibition	%	4.18
	8080516	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	56.0	CHEMBL3863	Homo sapiens	Inhibition	%	56.0
	8080631	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.89	CHEMBL3863	Homo sapiens	Inhibition	%	3.89
	8081019	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.71	CHEMBL3863	Homo sapiens	Inhibition	%	-0.71
	8081154	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.27	CHEMBL3863	Homo sapiens	Inhibition	%	4.27
	8081522	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	73.76	CHEMBL3863	Homo sapiens	Inhibition	%	73.76
	8081849	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.38	CHEMBL3863	Homo sapiens	Inhibition	%	1.38
	8082101	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.73	CHEMBL3863	Homo sapiens	Inhibition	%	-0.73
	8082214	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.35	CHEMBL3863	Homo sapiens	Inhibition	%	3.35
	8082438	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.67	CHEMBL3863	Homo sapiens	Inhibition	%	4.67
	8082611	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	26.62	CHEMBL3863	Homo sapiens	Inhibition	%	26.62
	8082734	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.65	CHEMBL3863	Homo sapiens	Inhibition	%	2.65
	8082958	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.61	CHEMBL3863	Homo sapiens	Inhibition	%	3.61
	8083114	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.9	CHEMBL3863	Homo sapiens	Inhibition	%	5.9
	8083437	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.96	CHEMBL3863	Homo sapiens	Inhibition	%	0.96
	8083691	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.75	CHEMBL3863	Homo sapiens	Inhibition	%	2.75
	8084025	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	26.32	CHEMBL3863	Homo sapiens	Inhibition	%	26.32
	8084210	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	12.57	CHEMBL3863	Homo sapiens	Inhibition	%	12.57
	8084552	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.68	CHEMBL3863	Homo sapiens	Inhibition	%	2.68
	8084713	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	22.9	CHEMBL3863	Homo sapiens	Inhibition	%	22.9
	8085035	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.34	CHEMBL3863	Homo sapiens	Inhibition	%	2.34
	8085291	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.01	CHEMBL3863	Homo sapiens	Inhibition	%	-4.01
	8085623	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.32	CHEMBL3863	Homo sapiens	Inhibition	%	5.32
	8085812	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	62.17	CHEMBL3863	Homo sapiens	Inhibition	%	62.17
	8086151	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	5.12	CHEMBL3863	Homo sapiens	Inhibition	%	5.12
	8086313	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.71	CHEMBL3863	Homo sapiens	Inhibition	%	1.71
	8086537	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.76	CHEMBL3863	Homo sapiens	Inhibition	%	5.76
	8086636	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.02	CHEMBL3863	Homo sapiens	Inhibition	%	1.02
	8087071	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.0	CHEMBL3863	Homo sapiens	Inhibition	%	5.0
	8087229	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.88	CHEMBL3863	Homo sapiens	Inhibition	%	2.88
	8087567	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.01	CHEMBL3863	Homo sapiens	Inhibition	%	4.01
	8087705	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.44	CHEMBL3863	Homo sapiens	Inhibition	%	6.44
	8087929	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.04	CHEMBL3863	Homo sapiens	Inhibition	%	-1.04
	8088071	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.72	CHEMBL3863	Homo sapiens	Inhibition	%	6.72
	8088443	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.98	CHEMBL3863	Homo sapiens	Inhibition	%	1.98
	8088571	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.25	CHEMBL3863	Homo sapiens	Inhibition	%	5.25
	8088888	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.47	CHEMBL3863	Homo sapiens	Inhibition	%	5.47
	8089240	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.94	CHEMBL3863	Homo sapiens	Inhibition	%	7.94
	8089388	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.84	CHEMBL3863	Homo sapiens	Inhibition	%	2.84
	8089732	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.52	CHEMBL3863	Homo sapiens	Inhibition	%	1.52
	8089912	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.05	CHEMBL3863	Homo sapiens	Inhibition	%	3.05
	8090136	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.58	CHEMBL3863	Homo sapiens	Inhibition	%	0.58
	8090301	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	12.38	CHEMBL3863	Homo sapiens	Inhibition	%	12.38
	8090468	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.52	CHEMBL3863	Homo sapiens	Inhibition	%	2.52
	8090831	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.95	CHEMBL3863	Homo sapiens	Inhibition	%	2.95
	8091036	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.17	CHEMBL3863	Homo sapiens	Inhibition	%	3.17
	8091397	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	33.78	CHEMBL3863	Homo sapiens	Inhibition	%	33.78
	8091552	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.86	CHEMBL3863	Homo sapiens	Inhibition	%	2.86
	8091776	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.89	CHEMBL3863	Homo sapiens	Inhibition	%	2.89
	8091892	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.46	CHEMBL3863	Homo sapiens	Inhibition	%	5.46
	8092253	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.79	CHEMBL3863	Homo sapiens	Inhibition	%	0.79
	8092404	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.69	CHEMBL3863	Homo sapiens	Inhibition	%	4.69
	8092776	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.09	CHEMBL3863	Homo sapiens	Inhibition	%	0.09
	8092905	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.69	CHEMBL3863	Homo sapiens	Inhibition	%	6.69
	8093129	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.01	CHEMBL3863	Homo sapiens	Inhibition	%	-0.01
	8093217	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.85	CHEMBL3863	Homo sapiens	Inhibition	%	1.85
	8093581	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.47	CHEMBL3863	Homo sapiens	Inhibition	%	-0.47
	8093720	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	13.53	CHEMBL3863	Homo sapiens	Inhibition	%	13.53
	8093944	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.35	CHEMBL3863	Homo sapiens	Inhibition	%	-1.35
	8094064	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.41	CHEMBL3863	Homo sapiens	Inhibition	%	1.41
	8094468	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.09	CHEMBL3863	Homo sapiens	Inhibition	%	2.09
	8094643	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	61.67	CHEMBL3863	Homo sapiens	Inhibition	%	61.67
	8094799	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.13	CHEMBL3863	Homo sapiens	Inhibition	%	3.13
	8095023	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.97	CHEMBL3863	Homo sapiens	Inhibition	%	1.97
	8095163	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	4.48	CHEMBL3863	Homo sapiens	Inhibition	%	4.48
	8095366	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.08	CHEMBL3863	Homo sapiens	Inhibition	%	4.08
	8095590	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.97	CHEMBL3863	Homo sapiens	Inhibition	%	5.97
	8095731	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	71.33	CHEMBL3863	Homo sapiens	Inhibition	%	71.33
	8096103	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	5.2	CHEMBL3863	Homo sapiens	Inhibition	%	5.2
	8096220	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.47	CHEMBL3863	Homo sapiens	Inhibition	%	4.47
	8096583	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.74	CHEMBL3863	Homo sapiens	Inhibition	%	1.74
	8096739	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.12	CHEMBL3863	Homo sapiens	Inhibition	%	8.12
	8096963	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.51	CHEMBL3863	Homo sapiens	Inhibition	%	5.51
	8097110	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.23	CHEMBL3863	Homo sapiens	Inhibition	%	0.23
	8097417	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	14.1	CHEMBL3863	Homo sapiens	Inhibition	%	14.1
	8097641	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.3	CHEMBL3863	Homo sapiens	Inhibition	%	1.3
	8097791	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	9.57	CHEMBL3863	Homo sapiens	Inhibition	%	9.57
	8098148	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.96	CHEMBL3863	Homo sapiens	Inhibition	%	-1.96
	8098268	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.37	CHEMBL3863	Homo sapiens	Inhibition	%	0.37
	8098492	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.82	CHEMBL3863	Homo sapiens	Inhibition	%	1.82
	8098672	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.25	CHEMBL3863	Homo sapiens	Inhibition	%	1.25
	8098857	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	84.31	CHEMBL3863	Homo sapiens	Inhibition	%	84.31
	8099225	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.95	CHEMBL3863	Homo sapiens	Inhibition	%	2.95
	8099367	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.39	CHEMBL3863	Homo sapiens	Inhibition	%	3.39
	8099785	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	40.03	CHEMBL3863	Homo sapiens	Inhibition	%	40.03
	8099932	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.31	CHEMBL3863	Homo sapiens	Inhibition	%	6.31
	8100302	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.79	CHEMBL3863	Homo sapiens	Inhibition	%	-1.79
	8100418	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.95	CHEMBL3863	Homo sapiens	Inhibition	%	7.95
	8100642	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.51	CHEMBL3863	Homo sapiens	Inhibition	%	5.51
	8100782	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.75	CHEMBL3863	Homo sapiens	Inhibition	%	2.75
	8101166	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	15.21	CHEMBL3863	Homo sapiens	Inhibition	%	15.21
	8101308	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.66	CHEMBL3863	Homo sapiens	Inhibition	%	-0.66
	8101717	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.79	CHEMBL3863	Homo sapiens	Inhibition	%	-0.79
	8101970	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.07	CHEMBL3863	Homo sapiens	Inhibition	%	6.07
	8102125	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.68	CHEMBL3863	Homo sapiens	Inhibition	%	-1.68
	8102480	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.66	CHEMBL3863	Homo sapiens	Inhibition	%	1.66
	8102824	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.3	CHEMBL3863	Homo sapiens	Inhibition	%	2.3
	8103002	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.71	CHEMBL3863	Homo sapiens	Inhibition	%	0.71
	8103198	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.85	CHEMBL3863	Homo sapiens	Inhibition	%	5.85
	8103422	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	29.93	CHEMBL3863	Homo sapiens	Inhibition	%	29.93
	8103560	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.93	CHEMBL3863	Homo sapiens	Inhibition	%	1.93
	8103710	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.09	CHEMBL3863	Homo sapiens	Inhibition	%	5.09
	8103934	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.83	CHEMBL3863	Homo sapiens	Inhibition	%	3.83
	8104119	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.7	CHEMBL3863	Homo sapiens	Inhibition	%	2.7
	8104267	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	10.71	CHEMBL3863	Homo sapiens	Inhibition	%	10.71
	8104491	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.16	CHEMBL3863	Homo sapiens	Inhibition	%	6.16
	8104637	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	12.58	CHEMBL3863	Homo sapiens	Inhibition	%	12.58
	8104975	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	8.1	CHEMBL3863	Homo sapiens	Inhibition	%	8.1
	8105115	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.41	CHEMBL3863	Homo sapiens	Inhibition	%	-0.41
	8105339	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.79	CHEMBL3863	Homo sapiens	Inhibition	%	1.79
	8105505	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.52	CHEMBL3863	Homo sapiens	Inhibition	%	0.52
	8105643	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.47	CHEMBL3863	Homo sapiens	Inhibition	%	-1.47
	8105867	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.12	CHEMBL3863	Homo sapiens	Inhibition	%	4.12
	8105923	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.8	CHEMBL3863	Homo sapiens	Inhibition	%	1.8
	8106147	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.69	CHEMBL3863	Homo sapiens	Inhibition	%	2.69
	8106312	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.67	CHEMBL3863	Homo sapiens	Inhibition	%	-1.67
	8106468	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	6.22	CHEMBL3863	Homo sapiens	Inhibition	%	6.22
	8106692	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.16	CHEMBL3863	Homo sapiens	Inhibition	%	-1.16
	8106821	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.39	CHEMBL3863	Homo sapiens	Inhibition	%	0.39
	8107166	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	5.37	CHEMBL3863	Homo sapiens	Inhibition	%	5.37
	8107338	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.33	CHEMBL3863	Homo sapiens	Inhibition	%	1.33
	8107763	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.07	CHEMBL3863	Homo sapiens	Inhibition	%	3.07
	8107898	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	4.25	CHEMBL3863	Homo sapiens	Inhibition	%	4.25
	8108280	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.48	CHEMBL3863	Homo sapiens	Inhibition	%	4.48
	8108455	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.03	CHEMBL3863	Homo sapiens	Inhibition	%	3.03
	8108826	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	11.99	CHEMBL3863	Homo sapiens	Inhibition	%	11.99
	8108968	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.15	CHEMBL3863	Homo sapiens	Inhibition	%	1.15
	8109306	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.0	CHEMBL3863	Homo sapiens	Inhibition	%	6.0
	8109660	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.84	CHEMBL3863	Homo sapiens	Inhibition	%	-1.84
	8109831	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.79	CHEMBL3863	Homo sapiens	Inhibition	%	3.79
	8110187	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.16	CHEMBL3863	Homo sapiens	Inhibition	%	5.16
	8110466	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.97	CHEMBL3863	Homo sapiens	Inhibition	%	1.97
	8110632	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.04	CHEMBL3863	Homo sapiens	Inhibition	%	0.04
	8111014	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-3.02	CHEMBL3863	Homo sapiens	Inhibition	%	-3.02
	8111137	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.25	CHEMBL3863	Homo sapiens	Inhibition	%	1.25
	8111361	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.01	CHEMBL3863	Homo sapiens	Inhibition	%	1.01
	8111488	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.68	CHEMBL3863	Homo sapiens	Inhibition	%	2.68
	8111654	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.94	CHEMBL3863	Homo sapiens	Inhibition	%	1.94
	8111878	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.49	CHEMBL3863	Homo sapiens	Inhibition	%	0.49
	8112083	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.44	CHEMBL3863	Homo sapiens	Inhibition	%	5.44
	8112220	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.01	CHEMBL3863	Homo sapiens	Inhibition	%	0.01
	8112444	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.3	CHEMBL3863	Homo sapiens	Inhibition	%	0.3
	8112612	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.59	CHEMBL3863	Homo sapiens	Inhibition	%	6.59
	8112784	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.6	CHEMBL3863	Homo sapiens	Inhibition	%	1.6
	8113008	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.33	CHEMBL3863	Homo sapiens	Inhibition	%	2.33
	8113160	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.31	CHEMBL3863	Homo sapiens	Inhibition	%	4.31
	8113296	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.02	CHEMBL3863	Homo sapiens	Inhibition	%	2.02
	8113520	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.53	CHEMBL3863	Homo sapiens	Inhibition	%	-0.53
	8113644	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	18.21	CHEMBL3863	Homo sapiens	Inhibition	%	18.21
	8113984	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.13	CHEMBL3863	Homo sapiens	Inhibition	%	-1.13
	8114160	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.62	CHEMBL3863	Homo sapiens	Inhibition	%	4.62
	8114516	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.24	CHEMBL3863	Homo sapiens	Inhibition	%	5.24
	8114792	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.69	CHEMBL3863	Homo sapiens	Inhibition	%	2.69
	8114958	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.55	CHEMBL3863	Homo sapiens	Inhibition	%	1.55
	8115182	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.08	CHEMBL3863	Homo sapiens	Inhibition	%	2.08
	8115347	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.03	CHEMBL3863	Homo sapiens	Inhibition	%	-0.03
	8115691	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.88	CHEMBL3863	Homo sapiens	Inhibition	%	1.88
	8115824	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	19.2	CHEMBL3863	Homo sapiens	Inhibition	%	19.2
	8116207	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	13.9	CHEMBL3863	Homo sapiens	Inhibition	%	13.9
	8116410	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.17	CHEMBL3863	Homo sapiens	Inhibition	%	4.17
	8116768	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.07	CHEMBL3863	Homo sapiens	Inhibition	%	0.07
	8116940	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	35.02	CHEMBL3863	Homo sapiens	Inhibition	%	35.02
	8117335	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.18	CHEMBL3863	Homo sapiens	Inhibition	%	1.18
	8117493	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	12.87	CHEMBL3863	Homo sapiens	Inhibition	%	12.87
	8117847	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.36	CHEMBL3863	Homo sapiens	Inhibition	%	0.36
	8117985	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.0	CHEMBL3863	Homo sapiens	Inhibition	%	2.0
	8118209	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	7.05	CHEMBL3863	Homo sapiens	Inhibition	%	7.05
	8118325	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.74	CHEMBL3863	Homo sapiens	Inhibition	%	4.74
	8118497	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.2	CHEMBL3863	Homo sapiens	Inhibition	%	6.2
	8118721	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.11	CHEMBL3863	Homo sapiens	Inhibition	%	4.11
	8118857	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.44	CHEMBL3863	Homo sapiens	Inhibition	%	6.44
	8119128	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.21	CHEMBL3863	Homo sapiens	Inhibition	%	2.21
	8119511	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.65	CHEMBL3863	Homo sapiens	Inhibition	%	1.65
	8119678	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.44	CHEMBL3863	Homo sapiens	Inhibition	%	-2.44
	8120021	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.6	CHEMBL3863	Homo sapiens	Inhibition	%	2.6
	8120160	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.11	CHEMBL3863	Homo sapiens	Inhibition	%	1.11
	8120384	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.32	CHEMBL3863	Homo sapiens	Inhibition	%	3.32
	8120544	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.57	CHEMBL3863	Homo sapiens	Inhibition	%	2.57
	8120745	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	13.38	CHEMBL3863	Homo sapiens	Inhibition	%	13.38
	8121097	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.8	CHEMBL3863	Homo sapiens	Inhibition	%	0.8
	8121269	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.54	CHEMBL3863	Homo sapiens	Inhibition	%	2.54
	8121493	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.43	CHEMBL3863	Homo sapiens	Inhibition	%	3.43
	8121660	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.94	CHEMBL3863	Homo sapiens	Inhibition	%	1.94
	8121823	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.36	CHEMBL3863	Homo sapiens	Inhibition	%	5.36
	8122168	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.08	CHEMBL3863	Homo sapiens	Inhibition	%	-2.08
	8122530	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	22.36	CHEMBL3863	Homo sapiens	Inhibition	%	22.36
	8122650	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.66	CHEMBL3863	Homo sapiens	Inhibition	%	5.66
	8123041	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.47	CHEMBL3863	Homo sapiens	Inhibition	%	7.47
	8123183	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.73	CHEMBL3863	Homo sapiens	Inhibition	%	0.73
	8123407	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.99	CHEMBL3863	Homo sapiens	Inhibition	%	0.99
	8123461	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	18.07	CHEMBL3863	Homo sapiens	Inhibition	%	18.07
	8123835	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.18	CHEMBL3863	Homo sapiens	Inhibition	%	3.18
	8124002	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.1	CHEMBL3863	Homo sapiens	Inhibition	%	-2.1
	8124226	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-5.45	CHEMBL3863	Homo sapiens	Inhibition	%	-5.45
	8124345	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.01	CHEMBL3863	Homo sapiens	Inhibition	%	4.01
	8124708	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.2	CHEMBL3863	Homo sapiens	Inhibition	%	1.2
	8124873	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.38	CHEMBL3863	Homo sapiens	Inhibition	%	1.38
	8125074	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.88	CHEMBL3863	Homo sapiens	Inhibition	%	3.88
	8125298	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	12.96	CHEMBL3863	Homo sapiens	Inhibition	%	12.96
	8125428	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.5	CHEMBL3863	Homo sapiens	Inhibition	%	-0.5
	8125820	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.65	CHEMBL3863	Homo sapiens	Inhibition	%	3.65
	8125984	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.1	CHEMBL3863	Homo sapiens	Inhibition	%	-0.1
	8126148	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.59	CHEMBL3863	Homo sapiens	Inhibition	%	9.59
	8126372	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	36.32	CHEMBL3863	Homo sapiens	Inhibition	%	36.32
	8126487	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.19	CHEMBL3863	Homo sapiens	Inhibition	%	-1.19
	8126847	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	67.28	CHEMBL3863	Homo sapiens	Inhibition	%	67.28
	8126969	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.08	CHEMBL3863	Homo sapiens	Inhibition	%	5.08
	8127193	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	8.65	CHEMBL3863	Homo sapiens	Inhibition	%	8.65
	8127360	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.25	CHEMBL3863	Homo sapiens	Inhibition	%	4.25
	8127726	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.29	CHEMBL3863	Homo sapiens	Inhibition	%	5.29
	8127790	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.42	CHEMBL3863	Homo sapiens	Inhibition	%	1.42
	8128014	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.93	CHEMBL3863	Homo sapiens	Inhibition	%	2.93
	8128166	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.61	CHEMBL3863	Homo sapiens	Inhibition	%	1.61
	8128557	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.19	CHEMBL3863	Homo sapiens	Inhibition	%	1.19
	8128676	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	38.2	CHEMBL3863	Homo sapiens	Inhibition	%	38.2
	8129037	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.22	CHEMBL3863	Homo sapiens	Inhibition	%	1.22
	8129208	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.39	CHEMBL3863	Homo sapiens	Inhibition	%	-0.39
	8129621	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.19	CHEMBL3863	Homo sapiens	Inhibition	%	2.19
	8129760	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.81	CHEMBL3863	Homo sapiens	Inhibition	%	0.81
	8130145	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	5.03	CHEMBL3863	Homo sapiens	Inhibition	%	5.03
	8130317	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.6	CHEMBL3863	Homo sapiens	Inhibition	%	-0.6
	8130701	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	65.58	CHEMBL3863	Homo sapiens	Inhibition	%	65.58
	8130817	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.79	CHEMBL3863	Homo sapiens	Inhibition	%	3.79
	8131041	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.15	CHEMBL3863	Homo sapiens	Inhibition	%	5.15
	8131180	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.05	CHEMBL3863	Homo sapiens	Inhibition	%	6.05
	8131524	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.15	CHEMBL3863	Homo sapiens	Inhibition	%	0.15
	8131691	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.42	CHEMBL3863	Homo sapiens	Inhibition	%	5.42
	8132056	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	7.85	CHEMBL3863	Homo sapiens	Inhibition	%	7.85
	8132342	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.96	CHEMBL3863	Homo sapiens	Inhibition	%	-1.96
	8132489	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.79	CHEMBL3863	Homo sapiens	Inhibition	%	2.79
	8132713	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.89	CHEMBL3863	Homo sapiens	Inhibition	%	0.89
	8132881	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.46	CHEMBL3863	Homo sapiens	Inhibition	%	-1.46
	8133002	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.24	CHEMBL3863	Homo sapiens	Inhibition	%	1.24
	8133226	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.11	CHEMBL3863	Homo sapiens	Inhibition	%	4.11
	8133364	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.72	CHEMBL3863	Homo sapiens	Inhibition	%	0.72
	8133536	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.79	CHEMBL3863	Homo sapiens	Inhibition	%	0.79
	8133760	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.42	CHEMBL3863	Homo sapiens	Inhibition	%	-1.42
	8133940	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	6.28	CHEMBL3863	Homo sapiens	Inhibition	%	6.28
	8134088	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.0	CHEMBL3863	Homo sapiens	Inhibition	%	-1.0
	8134312	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.28	CHEMBL3863	Homo sapiens	Inhibition	%	-1.28
	8134472	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.2	CHEMBL3863	Homo sapiens	Inhibition	%	3.2
	8134656	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.24	CHEMBL3863	Homo sapiens	Inhibition	%	-2.24
	8134880	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	3.18	CHEMBL3863	Homo sapiens	Inhibition	%	3.18
	8135040	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.68	CHEMBL3863	Homo sapiens	Inhibition	%	6.68
	8135379	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.89	CHEMBL3863	Homo sapiens	Inhibition	%	3.89
	8135520	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	13.77	CHEMBL3863	Homo sapiens	Inhibition	%	13.77
	8135865	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.01	CHEMBL3863	Homo sapiens	Inhibition	%	1.01
	8136033	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.52	CHEMBL3863	Homo sapiens	Inhibition	%	3.52
	8136257	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	8.09	CHEMBL3863	Homo sapiens	Inhibition	%	8.09
	8136401	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.85	CHEMBL3863	Homo sapiens	Inhibition	%	4.85
	8136691	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.45	CHEMBL3863	Homo sapiens	Inhibition	%	-0.45
	8137050	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.46	CHEMBL3863	Homo sapiens	Inhibition	%	4.46
	8137213	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.19	CHEMBL3863	Homo sapiens	Inhibition	%	2.19
	8137557	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.84	CHEMBL3863	Homo sapiens	Inhibition	%	-2.84
	8137705	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.85	CHEMBL3863	Homo sapiens	Inhibition	%	1.85
	8138095	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.24	CHEMBL3863	Homo sapiens	Inhibition	%	0.24
	8138274	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.69	CHEMBL3863	Homo sapiens	Inhibition	%	1.69
	8138646	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.39	CHEMBL3863	Homo sapiens	Inhibition	%	-3.39
	8138804	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.32	CHEMBL3863	Homo sapiens	Inhibition	%	2.32
	8139213	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.52	CHEMBL3863	Homo sapiens	Inhibition	%	3.52
	8139372	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	10.99	CHEMBL3863	Homo sapiens	Inhibition	%	10.99
	8139710	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.55	CHEMBL3863	Homo sapiens	Inhibition	%	5.55
	8139851	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.58	CHEMBL3863	Homo sapiens	Inhibition	%	5.58
	8140075	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	10.62	CHEMBL3863	Homo sapiens	Inhibition	%	10.62
	8140198	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.26	CHEMBL3863	Homo sapiens	Inhibition	%	5.26
	8140581	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.87	CHEMBL3863	Homo sapiens	Inhibition	%	3.87
	8140724	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	12.44	CHEMBL3863	Homo sapiens	Inhibition	%	12.44
	8141026	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.69	CHEMBL3863	Homo sapiens	Inhibition	%	1.69
	8141380	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.7	CHEMBL3863	Homo sapiens	Inhibition	%	0.7
	8141540	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.22	CHEMBL3863	Homo sapiens	Inhibition	%	1.22
	8141883	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.47	CHEMBL3863	Homo sapiens	Inhibition	%	-2.47
	8142044	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.21	CHEMBL3863	Homo sapiens	Inhibition	%	3.21
	8142268	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.6	CHEMBL3863	Homo sapiens	Inhibition	%	6.6
	8142436	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.56	CHEMBL3863	Homo sapiens	Inhibition	%	-0.56
	8142612	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.7	CHEMBL3863	Homo sapiens	Inhibition	%	0.7
	8142836	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.32	CHEMBL3863	Homo sapiens	Inhibition	%	3.32
	8142985	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.57	CHEMBL3863	Homo sapiens	Inhibition	%	-3.57
	8143140	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.09	CHEMBL3863	Homo sapiens	Inhibition	%	4.09
	8143364	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.44	CHEMBL3863	Homo sapiens	Inhibition	%	3.44
	8143551	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.76	CHEMBL3863	Homo sapiens	Inhibition	%	4.76
	8143710	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.68	CHEMBL3863	Homo sapiens	Inhibition	%	7.68
	8143934	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	39.83	CHEMBL3863	Homo sapiens	Inhibition	%	39.83
	8144048	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.19	CHEMBL3863	Homo sapiens	Inhibition	%	0.19
	8144411	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.14	CHEMBL3863	Homo sapiens	Inhibition	%	3.14
	8144541	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.33	CHEMBL3863	Homo sapiens	Inhibition	%	6.33
	8144765	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.57	CHEMBL3863	Homo sapiens	Inhibition	%	4.57
	8144918	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.98	CHEMBL3863	Homo sapiens	Inhibition	%	4.98
	8145055	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.17	CHEMBL3863	Homo sapiens	Inhibition	%	5.17
	8145279	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.32	CHEMBL3863	Homo sapiens	Inhibition	%	7.32
	8145368	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.76	CHEMBL3863	Homo sapiens	Inhibition	%	3.76
	8145716	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.4	CHEMBL3863	Homo sapiens	Inhibition	%	1.4
	8145877	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.4	CHEMBL3863	Homo sapiens	Inhibition	%	2.4
	8146101	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.18	CHEMBL3863	Homo sapiens	Inhibition	%	1.18
	8146221	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.94	CHEMBL3863	Homo sapiens	Inhibition	%	0.94
	8146605	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.95	CHEMBL3863	Homo sapiens	Inhibition	%	3.95
	8146772	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	12.09	CHEMBL3863	Homo sapiens	Inhibition	%	12.09
	8147165	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.75	CHEMBL3863	Homo sapiens	Inhibition	%	5.75
	8147307	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.1	CHEMBL3863	Homo sapiens	Inhibition	%	2.1
	8147684	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.56	CHEMBL3863	Homo sapiens	Inhibition	%	3.56
	8147871	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.07	CHEMBL3863	Homo sapiens	Inhibition	%	5.07
	8148253	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.37	CHEMBL3863	Homo sapiens	Inhibition	%	4.37
	8148367	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.25	CHEMBL3863	Homo sapiens	Inhibition	%	-0.25
	8148591	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.99	CHEMBL3863	Homo sapiens	Inhibition	%	4.99
	8148730	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	10.41	CHEMBL3863	Homo sapiens	Inhibition	%	10.41
	8149092	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.71	CHEMBL3863	Homo sapiens	Inhibition	%	6.71
	8149251	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.21	CHEMBL3863	Homo sapiens	Inhibition	%	-2.21
	8149609	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.32	CHEMBL3863	Homo sapiens	Inhibition	%	5.32
	8149707	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.91	CHEMBL3863	Homo sapiens	Inhibition	%	1.91
	8149931	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.8	CHEMBL3863	Homo sapiens	Inhibition	%	4.8
	8150056	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.35	CHEMBL3863	Homo sapiens	Inhibition	%	-3.35
	8150440	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.59	CHEMBL3863	Homo sapiens	Inhibition	%	0.59
	8150560	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.37	CHEMBL3863	Homo sapiens	Inhibition	%	0.37
	8150784	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.19	CHEMBL3863	Homo sapiens	Inhibition	%	1.19
	8150949	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	19.78	CHEMBL3863	Homo sapiens	Inhibition	%	19.78
	8151112	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.08	CHEMBL3863	Homo sapiens	Inhibition	%	-4.08
	8151336	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.68	CHEMBL3863	Homo sapiens	Inhibition	%	-2.68
	8151513	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.35	CHEMBL3863	Homo sapiens	Inhibition	%	2.35
	8151651	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.92	CHEMBL3863	Homo sapiens	Inhibition	%	3.92
	8151875	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.34	CHEMBL3863	Homo sapiens	Inhibition	%	3.34
	8152029	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.79	CHEMBL3863	Homo sapiens	Inhibition	%	3.79
	8152217	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.26	CHEMBL3863	Homo sapiens	Inhibition	%	7.26
	8152441	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.34	CHEMBL3863	Homo sapiens	Inhibition	%	2.34
	8152599	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.71	CHEMBL3863	Homo sapiens	Inhibition	%	7.71
	8152937	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.33	CHEMBL3863	Homo sapiens	Inhibition	%	6.33
	8153076	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.21	CHEMBL3863	Homo sapiens	Inhibition	%	3.21
	8153437	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.23	CHEMBL3863	Homo sapiens	Inhibition	%	5.23
	8153594	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.04	CHEMBL3863	Homo sapiens	Inhibition	%	-3.04
	8153818	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.67	CHEMBL3863	Homo sapiens	Inhibition	%	1.67
	8153951	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	8.53	CHEMBL3863	Homo sapiens	Inhibition	%	8.53
	8154272	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.23	CHEMBL3863	Homo sapiens	Inhibition	%	2.23
	8154398	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.46	CHEMBL3863	Homo sapiens	Inhibition	%	-2.46
	8154622	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.11	CHEMBL3863	Homo sapiens	Inhibition	%	0.11
	8154781	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.61	CHEMBL3863	Homo sapiens	Inhibition	%	-0.61
	8155125	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.9	CHEMBL3863	Homo sapiens	Inhibition	%	1.9
	8155301	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.77	CHEMBL3863	Homo sapiens	Inhibition	%	0.77
	8155686	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.89	CHEMBL3863	Homo sapiens	Inhibition	%	4.89
	8155864	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.56	CHEMBL3863	Homo sapiens	Inhibition	%	4.56
	8156226	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.21	CHEMBL3863	Homo sapiens	Inhibition	%	3.21
	8156438	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.45	CHEMBL3863	Homo sapiens	Inhibition	%	3.45
	8156588	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.22	CHEMBL3863	Homo sapiens	Inhibition	%	2.22
	8156812	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.05	CHEMBL3863	Homo sapiens	Inhibition	%	2.05
	8156955	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.2	CHEMBL3863	Homo sapiens	Inhibition	%	6.2
	8157299	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	8.82	CHEMBL3863	Homo sapiens	Inhibition	%	8.82
	8157440	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.48	CHEMBL3863	Homo sapiens	Inhibition	%	1.48
	8157664	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.12	CHEMBL3863	Homo sapiens	Inhibition	%	2.12
	8157794	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.56	CHEMBL3863	Homo sapiens	Inhibition	%	2.56
	8157955	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.03	CHEMBL3863	Homo sapiens	Inhibition	%	2.03
	8158179	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.88	CHEMBL3863	Homo sapiens	Inhibition	%	-0.88
	8158429	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.56	CHEMBL3863	Homo sapiens	Inhibition	%	4.56
	8158587	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	9.98	CHEMBL3863	Homo sapiens	Inhibition	%	9.98
	8158980	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.73	CHEMBL3863	Homo sapiens	Inhibition	%	3.73
	8159115	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.61	CHEMBL3863	Homo sapiens	Inhibition	%	4.61
	8159459	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.81	CHEMBL3863	Homo sapiens	Inhibition	%	-0.81
	8159814	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	32.22	CHEMBL3863	Homo sapiens	Inhibition	%	32.22
	8159955	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	5.43	CHEMBL3863	Homo sapiens	Inhibition	%	5.43
	8160316	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.16	CHEMBL3863	Homo sapiens	Inhibition	%	6.16
	8160466	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.14	CHEMBL3863	Homo sapiens	Inhibition	%	0.14
	8160760	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.06	CHEMBL3863	Homo sapiens	Inhibition	%	6.06
	8161134	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.78	CHEMBL3863	Homo sapiens	Inhibition	%	1.78
	8161277	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.99	CHEMBL3863	Homo sapiens	Inhibition	%	6.99
	8161626	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.34	CHEMBL3863	Homo sapiens	Inhibition	%	2.34
	8161988	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.81	CHEMBL3863	Homo sapiens	Inhibition	%	-0.81
	8162118	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.49	CHEMBL3863	Homo sapiens	Inhibition	%	4.49
	8162502	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.77	CHEMBL3863	Homo sapiens	Inhibition	%	-1.77
	8162755	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	9.27	CHEMBL3863	Homo sapiens	Inhibition	%	9.27
	8162903	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	28.5	CHEMBL3863	Homo sapiens	Inhibition	%	28.5
	8163127	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	78.37	CHEMBL3863	Homo sapiens	Inhibition	%	78.37
	8163296	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.23	CHEMBL3863	Homo sapiens	Inhibition	%	4.23
	8163430	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.86	CHEMBL3863	Homo sapiens	Inhibition	%	6.86
	8163654	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.58	CHEMBL3863	Homo sapiens	Inhibition	%	4.58
	8163777	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.14	CHEMBL3863	Homo sapiens	Inhibition	%	2.14
	8164135	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	79.51	CHEMBL3863	Homo sapiens	Inhibition	%	79.51
	8164275	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.74	CHEMBL3863	Homo sapiens	Inhibition	%	0.74
	8164499	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.49	CHEMBL3863	Homo sapiens	Inhibition	%	3.49
	8164654	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.68	CHEMBL3863	Homo sapiens	Inhibition	%	7.68
	8164798	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	18.51	CHEMBL3863	Homo sapiens	Inhibition	%	18.51
	8165022	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.7	CHEMBL3863	Homo sapiens	Inhibition	%	2.7
	8165092	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.48	CHEMBL3863	Homo sapiens	Inhibition	%	5.48
	8165316	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	24.5	CHEMBL3863	Homo sapiens	Inhibition	%	24.5
	8165457	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.88	CHEMBL3863	Homo sapiens	Inhibition	%	2.88
	8165600	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	45.06	CHEMBL3863	Homo sapiens	Inhibition	%	45.06
	8165824	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.17	CHEMBL3863	Homo sapiens	Inhibition	%	1.17
	8165950	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.55	CHEMBL3863	Homo sapiens	Inhibition	%	4.55
	8166312	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.04	CHEMBL3863	Homo sapiens	Inhibition	%	4.04
	8166442	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.05	CHEMBL3863	Homo sapiens	Inhibition	%	3.05
	8166666	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.51	CHEMBL3863	Homo sapiens	Inhibition	%	5.51
	8166767	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.11	CHEMBL3863	Homo sapiens	Inhibition	%	2.11
	8167079	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.46	CHEMBL3863	Homo sapiens	Inhibition	%	2.46
	8167444	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	11.16	CHEMBL3863	Homo sapiens	Inhibition	%	11.16
	8167608	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.24	CHEMBL3863	Homo sapiens	Inhibition	%	4.24
	8167965	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.64	CHEMBL3863	Homo sapiens	Inhibition	%	6.64
	8168089	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.15	CHEMBL3863	Homo sapiens	Inhibition	%	3.15
	8168313	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	8.16	CHEMBL3863	Homo sapiens	Inhibition	%	8.16
	8168454	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.13	CHEMBL3863	Homo sapiens	Inhibition	%	6.13
	8168814	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.83	CHEMBL3863	Homo sapiens	Inhibition	%	-0.83
	8168978	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	49.46	CHEMBL3863	Homo sapiens	Inhibition	%	49.46
	8169344	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.68	CHEMBL3863	Homo sapiens	Inhibition	%	4.68
	8169648	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.28	CHEMBL3863	Homo sapiens	Inhibition	%	6.28
	8169782	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.09	CHEMBL3863	Homo sapiens	Inhibition	%	4.09
	8170151	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.94	CHEMBL3863	Homo sapiens	Inhibition	%	1.94
	8170276	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.89	CHEMBL3863	Homo sapiens	Inhibition	%	2.89
	8170500	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.31	CHEMBL3863	Homo sapiens	Inhibition	%	4.31
	8170640	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.45	CHEMBL3863	Homo sapiens	Inhibition	%	-0.45
	8170999	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.12	CHEMBL3863	Homo sapiens	Inhibition	%	2.12
	8171196	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.61	CHEMBL3863	Homo sapiens	Inhibition	%	2.61
	8171413	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.36	CHEMBL3863	Homo sapiens	Inhibition	%	3.36
	8171778	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	58.46	CHEMBL3863	Homo sapiens	Inhibition	%	58.46
	8171931	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.15	CHEMBL3863	Homo sapiens	Inhibition	%	-1.15
	8172155	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.28	CHEMBL3863	Homo sapiens	Inhibition	%	0.28
	8172287	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.45	CHEMBL3863	Homo sapiens	Inhibition	%	4.45
	8172639	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	9.5	CHEMBL3863	Homo sapiens	Inhibition	%	9.5
	8172781	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	25.47	CHEMBL3863	Homo sapiens	Inhibition	%	25.47
	8173141	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.65	CHEMBL3863	Homo sapiens	Inhibition	%	0.65
	8173306	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.37	CHEMBL3863	Homo sapiens	Inhibition	%	4.37
	8173530	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	10.09	CHEMBL3863	Homo sapiens	Inhibition	%	10.09
	8173671	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.94	CHEMBL3863	Homo sapiens	Inhibition	%	2.94
	8173982	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	34.43	CHEMBL3863	Homo sapiens	Inhibition	%	34.43
	8174114	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.37	CHEMBL3863	Homo sapiens	Inhibition	%	3.37
	8174338	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.0	CHEMBL3863	Homo sapiens	Inhibition	%	5.0
	8174486	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.97	CHEMBL3863	Homo sapiens	Inhibition	%	1.97
	8174832	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.66	CHEMBL3863	Homo sapiens	Inhibition	%	2.66
	8174975	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.01	CHEMBL3863	Homo sapiens	Inhibition	%	6.01
	8175335	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	15.9	CHEMBL3863	Homo sapiens	Inhibition	%	15.9
	8175591	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.88	CHEMBL3863	Homo sapiens	Inhibition	%	7.88
	8175754	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.29	CHEMBL3863	Homo sapiens	Inhibition	%	2.29
	8175978	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.44	CHEMBL3863	Homo sapiens	Inhibition	%	4.44
	8176131	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.16	CHEMBL3863	Homo sapiens	Inhibition	%	8.16
	8176504	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.16	CHEMBL3863	Homo sapiens	Inhibition	%	2.16
	8176636	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	16.5	CHEMBL3863	Homo sapiens	Inhibition	%	16.5
	8176990	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	56.48	CHEMBL3863	Homo sapiens	Inhibition	%	56.48
	8177132	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.38	CHEMBL3863	Homo sapiens	Inhibition	%	1.38
	8177356	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.65	CHEMBL3863	Homo sapiens	Inhibition	%	4.65
	8177494	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.02	CHEMBL3863	Homo sapiens	Inhibition	%	5.02
	8177882	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.0	CHEMBL3863	Homo sapiens	Inhibition	%	8.0
	8178022	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.25	CHEMBL3863	Homo sapiens	Inhibition	%	4.25
	8178334	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.38	CHEMBL3863	Homo sapiens	Inhibition	%	2.38
	8178685	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.64	CHEMBL3863	Homo sapiens	Inhibition	%	3.64
	8178834	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.45	CHEMBL3863	Homo sapiens	Inhibition	%	2.45
	8179181	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.66	CHEMBL3863	Homo sapiens	Inhibition	%	4.66
	8179325	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.88	CHEMBL3863	Homo sapiens	Inhibition	%	3.88
	8179549	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	24.42	CHEMBL3863	Homo sapiens	Inhibition	%	24.42
	8179686	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.1	CHEMBL3863	Homo sapiens	Inhibition	%	1.1
	8179943	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.4	CHEMBL3863	Homo sapiens	Inhibition	%	5.4
	8180321	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.95	CHEMBL3863	Homo sapiens	Inhibition	%	-0.95
	8180477	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	41.05	CHEMBL3863	Homo sapiens	Inhibition	%	41.05
	8180849	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	7.78	CHEMBL3863	Homo sapiens	Inhibition	%	7.78
	8180982	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.19	CHEMBL3863	Homo sapiens	Inhibition	%	5.19
	8181206	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	24.71	CHEMBL3863	Homo sapiens	Inhibition	%	24.71
	8181337	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.51	CHEMBL3863	Homo sapiens	Inhibition	%	0.51
	8181701	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.43	CHEMBL3863	Homo sapiens	Inhibition	%	4.43
	8181840	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	26.97	CHEMBL3863	Homo sapiens	Inhibition	%	26.97
	8182227	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	45.03	CHEMBL3863	Homo sapiens	Inhibition	%	45.03
	8182367	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.32	CHEMBL3863	Homo sapiens	Inhibition	%	3.32
	8182591	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	5.39	CHEMBL3863	Homo sapiens	Inhibition	%	5.39
	8182683	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.68	CHEMBL3863	Homo sapiens	Inhibition	%	2.68
	8183029	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.89	CHEMBL3863	Homo sapiens	Inhibition	%	4.89
	8183178	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.32	CHEMBL3863	Homo sapiens	Inhibition	%	2.32
	8183402	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.41	CHEMBL3863	Homo sapiens	Inhibition	%	4.41
	8183531	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.27	CHEMBL3863	Homo sapiens	Inhibition	%	2.27
	8183897	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.46	CHEMBL3863	Homo sapiens	Inhibition	%	2.46
	8184033	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.52	CHEMBL3863	Homo sapiens	Inhibition	%	2.52
	8184257	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.12	CHEMBL3863	Homo sapiens	Inhibition	%	-2.12
	8184299	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.32	CHEMBL3863	Homo sapiens	Inhibition	%	6.32
	8184523	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.57	CHEMBL3863	Homo sapiens	Inhibition	%	5.57
	8184670	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.14	CHEMBL3863	Homo sapiens	Inhibition	%	-1.14
	8184827	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.89	CHEMBL3863	Homo sapiens	Inhibition	%	4.89
	8185051	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	36.49	CHEMBL3863	Homo sapiens	Inhibition	%	36.49
	8185200	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.28	CHEMBL3863	Homo sapiens	Inhibition	%	3.28
	8185555	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.59	CHEMBL3863	Homo sapiens	Inhibition	%	2.59
	8185686	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	15.92	CHEMBL3863	Homo sapiens	Inhibition	%	15.92
	8186049	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.64	CHEMBL3863	Homo sapiens	Inhibition	%	5.64
	8186190	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.47	CHEMBL3863	Homo sapiens	Inhibition	%	4.47
	8186414	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.19	CHEMBL3863	Homo sapiens	Inhibition	%	5.19
	8186578	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.69	CHEMBL3863	Homo sapiens	Inhibition	%	4.69
	8186941	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.85	CHEMBL3863	Homo sapiens	Inhibition	%	3.85
	8187039	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.25	CHEMBL3863	Homo sapiens	Inhibition	%	2.25
	8187263	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.69	CHEMBL3863	Homo sapiens	Inhibition	%	3.69
	8187387	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.42	CHEMBL3863	Homo sapiens	Inhibition	%	3.42
	8187759	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.52	CHEMBL3863	Homo sapiens	Inhibition	%	2.52
	8187888	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-1.71	CHEMBL3863	Homo sapiens	Inhibition	%	-1.71
	8188112	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.89	CHEMBL3863	Homo sapiens	Inhibition	%	2.89
	8188255	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	7.47	CHEMBL3863	Homo sapiens	Inhibition	%	7.47
	8188614	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.45	CHEMBL3863	Homo sapiens	Inhibition	%	-1.45
	8188888	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.02	CHEMBL3863	Homo sapiens	Inhibition	%	7.02
	8189036	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.79	CHEMBL3863	Homo sapiens	Inhibition	%	1.79
	8189416	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.72	CHEMBL3863	Homo sapiens	Inhibition	%	3.72
	8189565	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.11	CHEMBL3863	Homo sapiens	Inhibition	%	2.11
	8189921	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	25.03	CHEMBL3863	Homo sapiens	Inhibition	%	25.03
	8190053	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.57	CHEMBL3863	Homo sapiens	Inhibition	%	3.57
	8190277	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.42	CHEMBL3863	Homo sapiens	Inhibition	%	6.42
	8190417	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.07	CHEMBL3863	Homo sapiens	Inhibition	%	4.07
	8190778	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.8	CHEMBL3863	Homo sapiens	Inhibition	%	5.8
	8190942	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.24	CHEMBL3863	Homo sapiens	Inhibition	%	9.24
	8191304	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	7.28	CHEMBL3863	Homo sapiens	Inhibition	%	7.28
	8191624	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.04	CHEMBL3863	Homo sapiens	Inhibition	%	2.04
	8191746	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.19	CHEMBL3863	Homo sapiens	Inhibition	%	6.19
	8191970	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.88	CHEMBL3863	Homo sapiens	Inhibition	%	2.88
	8192119	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.44	CHEMBL3863	Homo sapiens	Inhibition	%	6.44
	8192472	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.42	CHEMBL3863	Homo sapiens	Inhibition	%	-0.42
	8192616	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.24	CHEMBL3863	Homo sapiens	Inhibition	%	3.24
	8192976	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.73	CHEMBL3863	Homo sapiens	Inhibition	%	0.73
	8193248	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.65	CHEMBL3863	Homo sapiens	Inhibition	%	4.65
	8193393	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.16	CHEMBL3863	Homo sapiens	Inhibition	%	1.16
	8193617	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.01	CHEMBL3863	Homo sapiens	Inhibition	%	0.01
	8193774	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	10.99	CHEMBL3863	Homo sapiens	Inhibition	%	10.99
	8193923	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.28	CHEMBL3863	Homo sapiens	Inhibition	%	-0.28
	8194147	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.14	CHEMBL3863	Homo sapiens	Inhibition	%	-0.14
	8194278	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.73	CHEMBL3863	Homo sapiens	Inhibition	%	4.73
	8194633	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.74	CHEMBL3863	Homo sapiens	Inhibition	%	3.74
	8194776	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.39	CHEMBL3863	Homo sapiens	Inhibition	%	6.39
	8195000	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.29	CHEMBL3863	Homo sapiens	Inhibition	%	4.29
	8195133	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	14.62	CHEMBL3863	Homo sapiens	Inhibition	%	14.62
	8195297	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.76	CHEMBL3863	Homo sapiens	Inhibition	%	2.76
	8195521	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.32	CHEMBL3863	Homo sapiens	Inhibition	%	6.32
	8195660	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.39	CHEMBL3863	Homo sapiens	Inhibition	%	4.39
	8195982	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.26	CHEMBL3863	Homo sapiens	Inhibition	%	3.26
	8196323	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.43	CHEMBL3863	Homo sapiens	Inhibition	%	6.43
	8196473	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	10.05	CHEMBL3863	Homo sapiens	Inhibition	%	10.05
	8196825	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.16	CHEMBL3863	Homo sapiens	Inhibition	%	-0.16
	8196966	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.01	CHEMBL3863	Homo sapiens	Inhibition	%	5.01
	8197190	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.19	CHEMBL3863	Homo sapiens	Inhibition	%	2.19
	8197327	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.65	CHEMBL3863	Homo sapiens	Inhibition	%	0.65
	8197602	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.31	CHEMBL3863	Homo sapiens	Inhibition	%	3.31
	8197966	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.57	CHEMBL3863	Homo sapiens	Inhibition	%	0.57
	8198123	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.84	CHEMBL3863	Homo sapiens	Inhibition	%	0.84
	8198485	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.79	CHEMBL3863	Homo sapiens	Inhibition	%	4.79
	8198615	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	9.92	CHEMBL3863	Homo sapiens	Inhibition	%	9.92
	8198839	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.35	CHEMBL3863	Homo sapiens	Inhibition	%	4.35
	8198970	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.59	CHEMBL3863	Homo sapiens	Inhibition	%	5.59
	8199342	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.67	CHEMBL3863	Homo sapiens	Inhibition	%	6.67
	8199476	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.73	CHEMBL3863	Homo sapiens	Inhibition	%	4.73
	8199863	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.14	CHEMBL3863	Homo sapiens	Inhibition	%	2.14
	8200001	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	8.27	CHEMBL3863	Homo sapiens	Inhibition	%	8.27
	8200225	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.06	CHEMBL3863	Homo sapiens	Inhibition	%	5.06
	8200329	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.65	CHEMBL3863	Homo sapiens	Inhibition	%	1.65
	8200668	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.99	CHEMBL3863	Homo sapiens	Inhibition	%	2.99
	8200818	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	70.61	CHEMBL3863	Homo sapiens	Inhibition	%	70.61
	8201042	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.97	CHEMBL3863	Homo sapiens	Inhibition	%	3.97
	8201172	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.53	CHEMBL3863	Homo sapiens	Inhibition	%	-1.53
	8201531	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.75	CHEMBL3863	Homo sapiens	Inhibition	%	2.75
	8201664	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.67	CHEMBL3863	Homo sapiens	Inhibition	%	-0.67
	8201943	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.99	CHEMBL3863	Homo sapiens	Inhibition	%	4.99
	8202307	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.69	CHEMBL3863	Homo sapiens	Inhibition	%	-1.69
	8202474	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.16	CHEMBL3863	Homo sapiens	Inhibition	%	4.16
	8202823	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	26.92	CHEMBL3863	Homo sapiens	Inhibition	%	26.92
	8203177	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.48	CHEMBL3863	Homo sapiens	Inhibition	%	7.48
	8203308	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.64	CHEMBL3863	Homo sapiens	Inhibition	%	-0.64
	8203678	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.81	CHEMBL3863	Homo sapiens	Inhibition	%	2.81
	8203812	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.41	CHEMBL3863	Homo sapiens	Inhibition	%	7.41
	8204036	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.14	CHEMBL3863	Homo sapiens	Inhibition	%	8.14
	8204202	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.96	CHEMBL3863	Homo sapiens	Inhibition	%	2.96
	8204563	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	28.94	CHEMBL3863	Homo sapiens	Inhibition	%	28.94
	8204668	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.76	CHEMBL3863	Homo sapiens	Inhibition	%	2.76
	8204892	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.19	CHEMBL3863	Homo sapiens	Inhibition	%	1.19
	8205007	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.19	CHEMBL3863	Homo sapiens	Inhibition	%	4.19
	8205380	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	39.6	CHEMBL3863	Homo sapiens	Inhibition	%	39.6
	8205516	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.37	CHEMBL3863	Homo sapiens	Inhibition	%	3.37
	8205879	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.3	CHEMBL3863	Homo sapiens	Inhibition	%	2.3
	8206011	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.16	CHEMBL3863	Homo sapiens	Inhibition	%	-0.16
	8206235	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.83	CHEMBL3863	Homo sapiens	Inhibition	%	-1.83
	8206287	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.72	CHEMBL3863	Homo sapiens	Inhibition	%	3.72
	8206511	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.0	CHEMBL3863	Homo sapiens	Inhibition	%	1.0
	8206654	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.78	CHEMBL3863	Homo sapiens	Inhibition	%	-1.78
	8206834	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.41	CHEMBL3863	Homo sapiens	Inhibition	%	3.41
	8207058	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	7.59	CHEMBL3863	Homo sapiens	Inhibition	%	7.59
	8207184	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.85	CHEMBL3863	Homo sapiens	Inhibition	%	5.85
	8207538	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.47	CHEMBL3863	Homo sapiens	Inhibition	%	4.47
	8207670	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.68	CHEMBL3863	Homo sapiens	Inhibition	%	2.68
	8207894	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.25	CHEMBL3863	Homo sapiens	Inhibition	%	4.25
	8208039	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.95	CHEMBL3863	Homo sapiens	Inhibition	%	5.95
	8208395	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	37.76	CHEMBL3863	Homo sapiens	Inhibition	%	37.76
	8208561	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.78	CHEMBL3863	Homo sapiens	Inhibition	%	2.78
	8208918	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.0	CHEMBL3863	Homo sapiens	Inhibition	%	4.0
	8209247	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.23	CHEMBL3863	Homo sapiens	Inhibition	%	1.23
	8209363	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.38	CHEMBL3863	Homo sapiens	Inhibition	%	2.38
	8209737	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.17	CHEMBL3863	Homo sapiens	Inhibition	%	1.17
	8209873	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.82	CHEMBL3863	Homo sapiens	Inhibition	%	1.82
	8210097	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	1.04	CHEMBL3863	Homo sapiens	Inhibition	%	1.04
	8210238	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.9	CHEMBL3863	Homo sapiens	Inhibition	%	3.9
	8210598	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.4	CHEMBL3863	Homo sapiens	Inhibition	%	-1.4
	8210857	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.36	CHEMBL3863	Homo sapiens	Inhibition	%	0.36
	8211001	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.64	CHEMBL3863	Homo sapiens	Inhibition	%	3.64
	8211395	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.66	CHEMBL3863	Homo sapiens	Inhibition	%	3.66
	8211518	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	34.99	CHEMBL3863	Homo sapiens	Inhibition	%	34.99
	8211742	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.65	CHEMBL3863	Homo sapiens	Inhibition	%	1.65
	8211871	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.7	CHEMBL3863	Homo sapiens	Inhibition	%	7.7
	8212227	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.09	CHEMBL3863	Homo sapiens	Inhibition	%	7.09
	8212368	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.02	CHEMBL3863	Homo sapiens	Inhibition	%	3.02
	8212725	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.9	CHEMBL3863	Homo sapiens	Inhibition	%	4.9
	8212895	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	9.17	CHEMBL3863	Homo sapiens	Inhibition	%	9.17
	8213119	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.12	CHEMBL3863	Homo sapiens	Inhibition	%	2.12
	8213248	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	22.31	CHEMBL3863	Homo sapiens	Inhibition	%	22.31
	8213576	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.33	CHEMBL3863	Homo sapiens	Inhibition	%	-1.33
	8213689	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.64	CHEMBL3863	Homo sapiens	Inhibition	%	4.64
	8213913	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.26	CHEMBL3863	Homo sapiens	Inhibition	%	3.26
	8214060	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.47	CHEMBL3863	Homo sapiens	Inhibition	%	1.47
	8214421	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.84	CHEMBL3863	Homo sapiens	Inhibition	%	3.84
	8214555	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.94	CHEMBL3863	Homo sapiens	Inhibition	%	-0.94
	8214779	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	12.13	CHEMBL3863	Homo sapiens	Inhibition	%	12.13
	8214931	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	10.35	CHEMBL3863	Homo sapiens	Inhibition	%	10.35
	8215182	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.07	CHEMBL3863	Homo sapiens	Inhibition	%	4.07
	8215335	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.12	CHEMBL3863	Homo sapiens	Inhibition	%	5.12
	8215559	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.27	CHEMBL3863	Homo sapiens	Inhibition	%	4.27
	8215723	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.58	CHEMBL3863	Homo sapiens	Inhibition	%	6.58
	8216066	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	13.39	CHEMBL3863	Homo sapiens	Inhibition	%	13.39
	8216185	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.72	CHEMBL3863	Homo sapiens	Inhibition	%	2.72
	8216545	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.09	CHEMBL3863	Homo sapiens	Inhibition	%	5.09
	8216683	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.62	CHEMBL3863	Homo sapiens	Inhibition	%	5.62
	8216907	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.29	CHEMBL3863	Homo sapiens	Inhibition	%	0.29
	8217041	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	9.11	CHEMBL3863	Homo sapiens	Inhibition	%	9.11
	8217439	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.49	CHEMBL3863	Homo sapiens	Inhibition	%	4.49
	8217570	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.92	CHEMBL3863	Homo sapiens	Inhibition	%	2.92
	8217895	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.04	CHEMBL3863	Homo sapiens	Inhibition	%	0.04
	8218234	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.18	CHEMBL3863	Homo sapiens	Inhibition	%	6.18
	8218361	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.09	CHEMBL3863	Homo sapiens	Inhibition	%	2.09
	8218585	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	7.26	CHEMBL3863	Homo sapiens	Inhibition	%	7.26
	8218728	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.73	CHEMBL3863	Homo sapiens	Inhibition	%	2.73
	8219083	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.05	CHEMBL3863	Homo sapiens	Inhibition	%	2.05
	8219243	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	66.27	CHEMBL3863	Homo sapiens	Inhibition	%	66.27
	8219493	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.03	CHEMBL3863	Homo sapiens	Inhibition	%	5.03
	8219878	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.99	CHEMBL3863	Homo sapiens	Inhibition	%	6.99
	8220047	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.23	CHEMBL3863	Homo sapiens	Inhibition	%	4.23
	8220400	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.55	CHEMBL3863	Homo sapiens	Inhibition	%	4.55
	8220514	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.86	CHEMBL3863	Homo sapiens	Inhibition	%	3.86
	8220738	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.79	CHEMBL3863	Homo sapiens	Inhibition	%	2.79
	8220876	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	18.25	CHEMBL3863	Homo sapiens	Inhibition	%	18.25
	8221236	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	23.17	CHEMBL3863	Homo sapiens	Inhibition	%	23.17
	8221369	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.89	CHEMBL3863	Homo sapiens	Inhibition	%	3.89
	8221593	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.58	CHEMBL3863	Homo sapiens	Inhibition	%	6.58
	8221758	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.19	CHEMBL3863	Homo sapiens	Inhibition	%	3.19
	8221889	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.45	CHEMBL3863	Homo sapiens	Inhibition	%	5.45
	8222113	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.68	CHEMBL3863	Homo sapiens	Inhibition	%	3.68
	8222211	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.32	CHEMBL3863	Homo sapiens	Inhibition	%	2.32
	8222569	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.47	CHEMBL3863	Homo sapiens	Inhibition	%	3.47
	8222911	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.86	CHEMBL3863	Homo sapiens	Inhibition	%	2.86
	8223055	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.09	CHEMBL3863	Homo sapiens	Inhibition	%	3.09
	8223408	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.41	CHEMBL3863	Homo sapiens	Inhibition	%	3.41
	8223569	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.61	CHEMBL3863	Homo sapiens	Inhibition	%	0.61
	8223819	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.08	CHEMBL3863	Homo sapiens	Inhibition	%	4.08
	8224043	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.53	CHEMBL3863	Homo sapiens	Inhibition	%	4.53
	8224205	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.07	CHEMBL3863	Homo sapiens	Inhibition	%	3.07
	8224375	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.29	CHEMBL3863	Homo sapiens	Inhibition	%	6.29
	8224599	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.95	CHEMBL3863	Homo sapiens	Inhibition	%	2.95
	8224734	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.2	CHEMBL3863	Homo sapiens	Inhibition	%	6.2
	8225072	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.51	CHEMBL3863	Homo sapiens	Inhibition	%	6.51
	8225206	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.8	CHEMBL3863	Homo sapiens	Inhibition	%	4.8
	8225430	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	11.45	CHEMBL3863	Homo sapiens	Inhibition	%	11.45
	8225568	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.92	CHEMBL3863	Homo sapiens	Inhibition	%	1.92
	8225927	CHEMBL1961912	GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.69	CHEMBL3863	Homo sapiens	Inhibition	%	3.69
	8226085	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	34.1	CHEMBL3863	Homo sapiens	Inhibition	%	34.1
	8226434	CHEMBL1961913	GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	6.75	CHEMBL3863	Homo sapiens	Inhibition	%	6.75
	10839464	CHEMBL2015495	Inhibition of PKD1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	85.0	CHEMBL3863	Homo sapiens	INH	%	85.0
	10839549	CHEMBL2015800	Inhibition of PKD1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	12.0	CHEMBL3863	Homo sapiens	Activity	%	12.0
	10840395	CHEMBL2016324	Inhibition of PKD1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	37.0	CHEMBL3863	Homo sapiens	Activity	%	37.0
	12047322	CHEMBL2157433	Inhibition of PKD1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	5.2	CHEMBL3863	Homo sapiens	INH	%	5.2
	12170745	CHEMBL2209466	Inhibition of PKD1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	80.0	CHEMBL3863	Homo sapiens	Activity	%	80.0
	12170876	CHEMBL2213195	Inhibition of PKD1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	76.0	CHEMBL3863	Homo sapiens	Activity	%	76.0
	12172248	CHEMBL2212478	Inhibition of PRKD1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	41.0	CHEMBL3863	Homo sapiens	Activity	%	41.0
	12257313	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	98.0	CHEMBL3863	Homo sapiens	Residual Activity	%	98.0
	12257314	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257315	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	99.0	CHEMBL3863	Homo sapiens	Residual Activity	%	99.0
	12257316	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12257317	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	86.0	CHEMBL3863	Homo sapiens	Residual Activity	%	86.0
	12257318	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12257319	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12257320	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	110.0	CHEMBL3863	Homo sapiens	Residual Activity	%	110.0
	12257321	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	94.0	CHEMBL3863	Homo sapiens	Residual Activity	%	94.0
	12257322	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	94.0	CHEMBL3863	Homo sapiens	Residual Activity	%	94.0
	12257323	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257324	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	76.0	CHEMBL3863	Homo sapiens	Residual Activity	%	76.0
	12257325	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	85.0	CHEMBL3863	Homo sapiens	Residual Activity	%	85.0
	12257326	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	22.0	CHEMBL3863	Homo sapiens	Residual Activity	%	22.0
	12257327	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	35.0	CHEMBL3863	Homo sapiens	Residual Activity	%	35.0
	12257328	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12257329	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12257330	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	110.0	CHEMBL3863	Homo sapiens	Residual Activity	%	110.0
	12257331	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257332	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	8.0	CHEMBL3863	Homo sapiens	Residual Activity	%	8.0
	12257333	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL3863	Homo sapiens	Residual Activity	%	101.0
	12257334	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	94.0	CHEMBL3863	Homo sapiens	Residual Activity	%	94.0
	12257335	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257336	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257337	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12257338	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	101.0	CHEMBL3863	Homo sapiens	Residual Activity	%	101.0
	12257339	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	80.0	CHEMBL3863	Homo sapiens	Residual Activity	%	80.0
	12257340	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	47.0	CHEMBL3863	Homo sapiens	Residual Activity	%	47.0
	12257341	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12257342	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257343	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	65.0	CHEMBL3863	Homo sapiens	Residual Activity	%	65.0
	12257344	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257345	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12257346	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	77.0	CHEMBL3863	Homo sapiens	Residual Activity	%	77.0
	12257347	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	81.0	CHEMBL3863	Homo sapiens	Residual Activity	%	81.0
	12257348	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	74.0	CHEMBL3863	Homo sapiens	Residual Activity	%	74.0
	12257349	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	78.0	CHEMBL3863	Homo sapiens	Residual Activity	%	78.0
	12257350	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	93.0	CHEMBL3863	Homo sapiens	Residual Activity	%	93.0
	12257351	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	109.0	CHEMBL3863	Homo sapiens	Residual Activity	%	109.0
	12257352	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257353	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12257354	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12257355	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	5.0	CHEMBL3863	Homo sapiens	Residual Activity	%	5.0
	12257356	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	6.0	CHEMBL3863	Homo sapiens	Residual Activity	%	6.0
	12257357	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257358	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257359	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12257360	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	78.0	CHEMBL3863	Homo sapiens	Residual Activity	%	78.0
	12257361	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	104.0	CHEMBL3863	Homo sapiens	Residual Activity	%	104.0
	12257362	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12257363	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	108.0	CHEMBL3863	Homo sapiens	Residual Activity	%	108.0
	12257364	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	77.0	CHEMBL3863	Homo sapiens	Residual Activity	%	77.0
	12257365	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	5.0	CHEMBL3863	Homo sapiens	Residual Activity	%	5.0
	12257366	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12257367	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	108.0	CHEMBL3863	Homo sapiens	Residual Activity	%	108.0
	12257368	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12257369	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	126.0	CHEMBL3863	Homo sapiens	Residual Activity	%	126.0
	12257370	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	113.0	CHEMBL3863	Homo sapiens	Residual Activity	%	113.0
	12257371	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	103.0	CHEMBL3863	Homo sapiens	Residual Activity	%	103.0
	12257372	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	110.0	CHEMBL3863	Homo sapiens	Residual Activity	%	110.0
	12257373	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	106.0	CHEMBL3863	Homo sapiens	Residual Activity	%	106.0
	12257374	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	85.0	CHEMBL3863	Homo sapiens	Residual Activity	%	85.0
	12257375	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	93.0	CHEMBL3863	Homo sapiens	Residual Activity	%	93.0
	12257376	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12257377	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL3863	Homo sapiens	Residual Activity	%	108.0
	12257378	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12257379	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	119.0	CHEMBL3863	Homo sapiens	Residual Activity	%	119.0
	12257380	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12257381	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	103.0	CHEMBL3863	Homo sapiens	Residual Activity	%	103.0
	12257382	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12257383	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	116.0	CHEMBL3863	Homo sapiens	Residual Activity	%	116.0
	12257384	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	101.0	CHEMBL3863	Homo sapiens	Residual Activity	%	101.0
	12257385	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	108.0	CHEMBL3863	Homo sapiens	Residual Activity	%	108.0
	12257386	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	93.0	CHEMBL3863	Homo sapiens	Residual Activity	%	93.0
	12257387	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	93.0	CHEMBL3863	Homo sapiens	Residual Activity	%	93.0
	12257388	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257389	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	105.0	CHEMBL3863	Homo sapiens	Residual Activity	%	105.0
	12257390	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	38.0	CHEMBL3863	Homo sapiens	Residual Activity	%	38.0
	12257391	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12257392	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL3863	Homo sapiens	Residual Activity	%	2.0
	12257393	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	113.0	CHEMBL3863	Homo sapiens	Residual Activity	%	113.0
	12257394	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	75.0	CHEMBL3863	Homo sapiens	Residual Activity	%	75.0
	12257395	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	111.0	CHEMBL3863	Homo sapiens	Residual Activity	%	111.0
	12257396	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	100.0	CHEMBL3863	Homo sapiens	Residual Activity	%	100.0
	12257397	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257398	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	113.0	CHEMBL3863	Homo sapiens	Residual Activity	%	113.0
	12257399	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12257400	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	123.0	CHEMBL3863	Homo sapiens	Residual Activity	%	123.0
	12257401	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	86.0	CHEMBL3863	Homo sapiens	Residual Activity	%	86.0
	12257402	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	113.0	CHEMBL3863	Homo sapiens	Residual Activity	%	113.0
	12257403	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12257404	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	56.0	CHEMBL3863	Homo sapiens	Residual Activity	%	56.0
	12257405	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12257406	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL3863	Homo sapiens	Residual Activity	%	90.0
	12257407	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	99.0	CHEMBL3863	Homo sapiens	Residual Activity	%	99.0
	12257408	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12257409	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	110.0	CHEMBL3863	Homo sapiens	Residual Activity	%	110.0
	12257410	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL3863	Homo sapiens	Residual Activity	%	98.0
	12257411	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	76.0	CHEMBL3863	Homo sapiens	Residual Activity	%	76.0
	12257412	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257413	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	41.0	CHEMBL3863	Homo sapiens	Residual Activity	%	41.0
	12257414	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL3863	Homo sapiens	Residual Activity	%	1.0
	12257415	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	85.0	CHEMBL3863	Homo sapiens	Residual Activity	%	85.0
	12257416	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257417	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	93.0	CHEMBL3863	Homo sapiens	Residual Activity	%	93.0
	12257418	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257419	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	59.0	CHEMBL3863	Homo sapiens	Residual Activity	%	59.0
	12257420	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12257421	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12257422	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	99.0	CHEMBL3863	Homo sapiens	Residual Activity	%	99.0
	12257423	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	64.0	CHEMBL3863	Homo sapiens	Residual Activity	%	64.0
	12257424	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	113.0	CHEMBL3863	Homo sapiens	Residual Activity	%	113.0
	12257425	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257426	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL3863	Homo sapiens	Residual Activity	%	99.0
	12257427	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	109.0	CHEMBL3863	Homo sapiens	Residual Activity	%	109.0
	12257428	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL3863	Homo sapiens	Residual Activity	%	90.0
	12257429	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	58.0	CHEMBL3863	Homo sapiens	Residual Activity	%	58.0
	12257430	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12257431	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	46.0	CHEMBL3863	Homo sapiens	Residual Activity	%	46.0
	12257432	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12257433	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12257434	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12257435	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	77.0	CHEMBL3863	Homo sapiens	Residual Activity	%	77.0
	12257436	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12257437	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	73.0	CHEMBL3863	Homo sapiens	Residual Activity	%	73.0
	12257438	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12257439	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	81.0	CHEMBL3863	Homo sapiens	Residual Activity	%	81.0
	12257440	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	94.0	CHEMBL3863	Homo sapiens	Residual Activity	%	94.0
	12257441	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	121.0	CHEMBL3863	Homo sapiens	Residual Activity	%	121.0
	12257442	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL3863	Homo sapiens	Residual Activity	%	2.0
	12257443	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257444	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12257445	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	32.0	CHEMBL3863	Homo sapiens	Residual Activity	%	32.0
	12257446	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12257447	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	80.0	CHEMBL3863	Homo sapiens	Residual Activity	%	80.0
	12257448	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	99.0	CHEMBL3863	Homo sapiens	Residual Activity	%	99.0
	12257449	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12257450	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12257451	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	90.0	CHEMBL3863	Homo sapiens	Residual Activity	%	90.0
	12257452	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	61.0	CHEMBL3863	Homo sapiens	Residual Activity	%	61.0
	12257453	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	82.0	CHEMBL3863	Homo sapiens	Residual Activity	%	82.0
	12257454	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL3863	Homo sapiens	Residual Activity	%	101.0
	12257455	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	110.0	CHEMBL3863	Homo sapiens	Residual Activity	%	110.0
	12257456	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12257457	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257458	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	110.0	CHEMBL3863	Homo sapiens	Residual Activity	%	110.0
	12257459	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	85.0	CHEMBL3863	Homo sapiens	Residual Activity	%	85.0
	12257460	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	73.0	CHEMBL3863	Homo sapiens	Residual Activity	%	73.0
	12257461	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	81.0	CHEMBL3863	Homo sapiens	Residual Activity	%	81.0
	12257462	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	103.0	CHEMBL3863	Homo sapiens	Residual Activity	%	103.0
	12257463	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	57.0	CHEMBL3863	Homo sapiens	Residual Activity	%	57.0
	12257464	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	109.0	CHEMBL3863	Homo sapiens	Residual Activity	%	109.0
	12257465	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	106.0	CHEMBL3863	Homo sapiens	Residual Activity	%	106.0
	12257466	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12257467	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12257468	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	91.0	CHEMBL3863	Homo sapiens	Residual Activity	%	91.0
	12257469	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	94.0	CHEMBL3863	Homo sapiens	Residual Activity	%	94.0
	12257470	CHEMBL2219119	Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	80.0	CHEMBL3863	Homo sapiens	Residual Activity	%	80.0
	12257471	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	117.0	CHEMBL3863	Homo sapiens	Residual Activity	%	117.0
	12257472	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	71.0	CHEMBL3863	Homo sapiens	Residual Activity	%	71.0
	12257473	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12257474	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	87.0	CHEMBL3863	Homo sapiens	Residual Activity	%	87.0
	12257475	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	49.0	CHEMBL3863	Homo sapiens	Residual Activity	%	49.0
	12257476	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	104.0	CHEMBL3863	Homo sapiens	Residual Activity	%	104.0
	12257477	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	59.0	CHEMBL3863	Homo sapiens	Residual Activity	%	59.0
	12257478	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	73.0	CHEMBL3863	Homo sapiens	Residual Activity	%	73.0
	12257479	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12257480	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	82.0	CHEMBL3863	Homo sapiens	Residual Activity	%	82.0
	12257481	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12257482	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12257483	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL3863	Homo sapiens	Residual Activity	%	82.0
	12257484	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	9.0	CHEMBL3863	Homo sapiens	Residual Activity	%	9.0
	12257485	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	8.0	CHEMBL3863	Homo sapiens	Residual Activity	%	8.0
	12257486	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	106.0	CHEMBL3863	Homo sapiens	Residual Activity	%	106.0
	12257487	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	90.0	CHEMBL3863	Homo sapiens	Residual Activity	%	90.0
	12257488	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	61.0	CHEMBL3863	Homo sapiens	Residual Activity	%	61.0
	12257489	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12257490	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	16.0	CHEMBL3863	Homo sapiens	Residual Activity	%	16.0
	12257491	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	103.0	CHEMBL3863	Homo sapiens	Residual Activity	%	103.0
	12257492	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12257493	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12258904	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12258905	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12258906	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	54.0	CHEMBL3863	Homo sapiens	Residual Activity	%	54.0
	12258907	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	23.0	CHEMBL3863	Homo sapiens	Residual Activity	%	23.0
	12258908	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	16.0	CHEMBL3863	Homo sapiens	Residual Activity	%	16.0
	12258909	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	66.0	CHEMBL3863	Homo sapiens	Residual Activity	%	66.0
	12258910	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	58.0	CHEMBL3863	Homo sapiens	Residual Activity	%	58.0
	12258911	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	22.0	CHEMBL3863	Homo sapiens	Residual Activity	%	22.0
	12258912	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12258913	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12258914	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	79.0	CHEMBL3863	Homo sapiens	Residual Activity	%	79.0
	12258915	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	77.0	CHEMBL3863	Homo sapiens	Residual Activity	%	77.0
	12258916	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12258917	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12258918	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12258919	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12258920	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	93.0	CHEMBL3863	Homo sapiens	Residual Activity	%	93.0
	12258921	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12258922	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12258923	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	12.0	CHEMBL3863	Homo sapiens	Residual Activity	%	12.0
	12258924	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL3863	Homo sapiens	Residual Activity	%	1.0
	12258925	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12258926	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	69.0	CHEMBL3863	Homo sapiens	Residual Activity	%	69.0
	12258927	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL3863	Homo sapiens	Residual Activity	%	106.0
	12258928	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12258929	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	106.0	CHEMBL3863	Homo sapiens	Residual Activity	%	106.0
	12258930	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12258931	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	58.0	CHEMBL3863	Homo sapiens	Residual Activity	%	58.0
	12258932	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	47.0	CHEMBL3863	Homo sapiens	Residual Activity	%	47.0
	12258933	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL3863	Homo sapiens	Residual Activity	%	4.0
	12258934	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	71.0	CHEMBL3863	Homo sapiens	Residual Activity	%	71.0
	12258935	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	98.0	CHEMBL3863	Homo sapiens	Residual Activity	%	98.0
	12258936	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	97.0	CHEMBL3863	Homo sapiens	Residual Activity	%	97.0
	12258937	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12258938	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12258939	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12258940	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12258941	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	67.0	CHEMBL3863	Homo sapiens	Residual Activity	%	67.0
	12258942	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	79.0	CHEMBL3863	Homo sapiens	Residual Activity	%	79.0
	12258943	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL3863	Homo sapiens	Residual Activity	%	103.0
	12258944	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	109.0	CHEMBL3863	Homo sapiens	Residual Activity	%	109.0
	12258945	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL3863	Homo sapiens	Residual Activity	%	98.0
	12258946	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	81.0	CHEMBL3863	Homo sapiens	Residual Activity	%	81.0
	12258947	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL3863	Homo sapiens	Residual Activity	%	102.0
	12258948	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL3863	Homo sapiens	Residual Activity	%	90.0
	12258949	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12258950	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	103.0	CHEMBL3863	Homo sapiens	Residual Activity	%	103.0
	12258951	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	115.0	CHEMBL3863	Homo sapiens	Residual Activity	%	115.0
	12258952	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	125.0	CHEMBL3863	Homo sapiens	Residual Activity	%	125.0
	12258953	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	43.0	CHEMBL3863	Homo sapiens	Residual Activity	%	43.0
	12258954	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	113.0	CHEMBL3863	Homo sapiens	Residual Activity	%	113.0
	12258955	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	36.0	CHEMBL3863	Homo sapiens	Residual Activity	%	36.0
	12258956	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	45.0	CHEMBL3863	Homo sapiens	Residual Activity	%	45.0
	12258957	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	77.0	CHEMBL3863	Homo sapiens	Residual Activity	%	77.0
	12258958	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	4.0	CHEMBL3863	Homo sapiens	Residual Activity	%	4.0
	12258959	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL3863	Homo sapiens	Residual Activity	%	96.0
	12258960	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3863	Homo sapiens	Residual Activity	%	0.0
	12258961	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	89.0	CHEMBL3863	Homo sapiens	Residual Activity	%	89.0
	12258962	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	19.0	CHEMBL3863	Homo sapiens	Residual Activity	%	19.0
	12258963	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12258964	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	86.0	CHEMBL3863	Homo sapiens	Residual Activity	%	86.0
	12258965	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL3863	Homo sapiens	Residual Activity	%	101.0
	12258966	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL3863	Homo sapiens	Residual Activity	%	105.0
	12258967	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	44.0	CHEMBL3863	Homo sapiens	Residual Activity	%	44.0
	12258968	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	66.0	CHEMBL3863	Homo sapiens	Residual Activity	%	66.0
	12258969	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	80.0	CHEMBL3863	Homo sapiens	Residual Activity	%	80.0
	12258970	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	65.0	CHEMBL3863	Homo sapiens	Residual Activity	%	65.0
	12258971	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	73.0	CHEMBL3863	Homo sapiens	Residual Activity	%	73.0
	12258972	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	12.0	CHEMBL3863	Homo sapiens	Residual Activity	%	12.0
	12258973	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	82.0	CHEMBL3863	Homo sapiens	Residual Activity	%	82.0
	12258974	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	54.0	CHEMBL3863	Homo sapiens	Residual Activity	%	54.0
	12258975	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	37.0	CHEMBL3863	Homo sapiens	Residual Activity	%	37.0
	12258976	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	20.0	CHEMBL3863	Homo sapiens	Residual Activity	%	20.0
	12258977	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	88.0	CHEMBL3863	Homo sapiens	Residual Activity	%	88.0
	12258978	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12258979	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	73.0	CHEMBL3863	Homo sapiens	Residual Activity	%	73.0
	12258980	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	71.0	CHEMBL3863	Homo sapiens	Residual Activity	%	71.0
	12258981	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	25.0	CHEMBL3863	Homo sapiens	Residual Activity	%	25.0
	12258982	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3863	Homo sapiens	Residual Activity	%	0.0
	12258983	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12258984	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	49.0	CHEMBL3863	Homo sapiens	Residual Activity	%	49.0
	12258985	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	79.0	CHEMBL3863	Homo sapiens	Residual Activity	%	79.0
	12258986	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	72.0	CHEMBL3863	Homo sapiens	Residual Activity	%	72.0
	12258987	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	18.0	CHEMBL3863	Homo sapiens	Residual Activity	%	18.0
	12258988	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	71.0	CHEMBL3863	Homo sapiens	Residual Activity	%	71.0
	12258989	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL3863	Homo sapiens	Residual Activity	%	90.0
	12258990	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	80.0	CHEMBL3863	Homo sapiens	Residual Activity	%	80.0
	12258991	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	52.0	CHEMBL3863	Homo sapiens	Residual Activity	%	52.0
	12258992	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	80.0	CHEMBL3863	Homo sapiens	Residual Activity	%	80.0
	12258993	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	76.0	CHEMBL3863	Homo sapiens	Residual Activity	%	76.0
	12258994	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	65.0	CHEMBL3863	Homo sapiens	Residual Activity	%	65.0
	12258995	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	79.0	CHEMBL3863	Homo sapiens	Residual Activity	%	79.0
	12258996	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	64.0	CHEMBL3863	Homo sapiens	Residual Activity	%	64.0
	12258997	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	29.0	CHEMBL3863	Homo sapiens	Residual Activity	%	29.0
	12258998	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	77.0	CHEMBL3863	Homo sapiens	Residual Activity	%	77.0
	12258999	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	3.0	CHEMBL3863	Homo sapiens	Residual Activity	%	3.0
	12259000	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	48.0	CHEMBL3863	Homo sapiens	Residual Activity	%	48.0
	12259001	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	59.0	CHEMBL3863	Homo sapiens	Residual Activity	%	59.0
	12259002	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	61.0	CHEMBL3863	Homo sapiens	Residual Activity	%	61.0
	12259003	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	57.0	CHEMBL3863	Homo sapiens	Residual Activity	%	57.0
	12259004	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	71.0	CHEMBL3863	Homo sapiens	Residual Activity	%	71.0
	12259005	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	32.0	CHEMBL3863	Homo sapiens	Residual Activity	%	32.0
	12259006	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	64.0	CHEMBL3863	Homo sapiens	Residual Activity	%	64.0
	12259007	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	86.0	CHEMBL3863	Homo sapiens	Residual Activity	%	86.0
	12259008	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL3863	Homo sapiens	Residual Activity	%	100.0
	12259009	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	84.0	CHEMBL3863	Homo sapiens	Residual Activity	%	84.0
	12259010	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL3863	Homo sapiens	Residual Activity	%	4.0
	12259011	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	71.0	CHEMBL3863	Homo sapiens	Residual Activity	%	71.0
	12259012	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	86.0	CHEMBL3863	Homo sapiens	Residual Activity	%	86.0
	12259013	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	-1.0	CHEMBL3863	Homo sapiens	Residual Activity	%	-1.0
	12259014	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	76.0	CHEMBL3863	Homo sapiens	Residual Activity	%	76.0
	12259015	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	51.0	CHEMBL3863	Homo sapiens	Residual Activity	%	51.0
	12259016	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	81.0	CHEMBL3863	Homo sapiens	Residual Activity	%	81.0
	12259017	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	69.0	CHEMBL3863	Homo sapiens	Residual Activity	%	69.0
	12259018	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	23.0	CHEMBL3863	Homo sapiens	Residual Activity	%	23.0
	12259019	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	100.0	CHEMBL3863	Homo sapiens	Residual Activity	%	100.0
	12259020	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	54.0	CHEMBL3863	Homo sapiens	Residual Activity	%	54.0
	12259021	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	68.0	CHEMBL3863	Homo sapiens	Residual Activity	%	68.0
	12259022	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	20.0	CHEMBL3863	Homo sapiens	Residual Activity	%	20.0
	12259023	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	57.0	CHEMBL3863	Homo sapiens	Residual Activity	%	57.0
	12259024	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	54.0	CHEMBL3863	Homo sapiens	Residual Activity	%	54.0
	12259025	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	62.0	CHEMBL3863	Homo sapiens	Residual Activity	%	62.0
	12259026	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	95.0	CHEMBL3863	Homo sapiens	Residual Activity	%	95.0
	12259027	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	81.0	CHEMBL3863	Homo sapiens	Residual Activity	%	81.0
	12259028	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	36.0	CHEMBL3863	Homo sapiens	Residual Activity	%	36.0
	12259029	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	64.0	CHEMBL3863	Homo sapiens	Residual Activity	%	64.0
	12259030	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	92.0	CHEMBL3863	Homo sapiens	Residual Activity	%	92.0
	12259031	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	4.0	CHEMBL3863	Homo sapiens	Residual Activity	%	4.0
	12259032	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	64.0	CHEMBL3863	Homo sapiens	Residual Activity	%	64.0
	12259033	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	104.0	CHEMBL3863	Homo sapiens	Residual Activity	%	104.0
	12259034	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	78.0	CHEMBL3863	Homo sapiens	Residual Activity	%	78.0
	12259035	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	83.0	CHEMBL3863	Homo sapiens	Residual Activity	%	83.0
	12259036	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	82.0	CHEMBL3863	Homo sapiens	Residual Activity	%	82.0
	12259037	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	36.0	CHEMBL3863	Homo sapiens	Residual Activity	%	36.0
	12259038	CHEMBL2219120	Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	39.0	CHEMBL3863	Homo sapiens	Residual Activity	%	39.0
	12662198	CHEMBL2330894	Inhibition of PKC mu (unknown origin)	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1		CHEMBL2326002	=	Ki	nM	2420.0	CHEMBL3863	Homo sapiens	Ki	nM	2420.0
	12672915	CHEMBL2341625	Inhibition of recombinant PKD1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	18.0	CHEMBL3863	Homo sapiens	Activity	%	18.0
	12672916	CHEMBL2341625	Inhibition of recombinant PKD1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	17.0	CHEMBL3863	Homo sapiens	Activity	%	17.0
	12693186	CHEMBL2343428	Inhibition of PKCmu (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	nM	10000.0
	12727683	CHEMBL2351396	Inhibition of PKCmu (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	84.0	CHEMBL3863	Homo sapiens	Activity	%	84.0
	12728969	CHEMBL2350147	Inhibition of PKCmu (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	12729850	CHEMBL2352437	Inhibition of PKCmu (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
	12730112	CHEMBL2351396	Inhibition of PKCmu (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL3863	Homo sapiens	Activity	%	99.0
Active	13300202	CHEMBL2384448	Inhibition of human PKD1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)C4)nn23)cn1		CHEMBL2380692		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	13300203	CHEMBL2384448	Inhibition of human PKD1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	13343234	CHEMBL2394361	Inhibition of protein kinase D1 (unknown origin) relative to control	B	N#CCCN[C@H]1CC[C@H](n2nnc3cnc4[nH]ccc4c32)CC1		CHEMBL2392480	=	Inhibition	%	44.0	CHEMBL3863	Homo sapiens	INH	%	44.0
	13374373	CHEMBL2406506	Inhibition of PKCmu (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	9.0	CHEMBL3863	Homo sapiens	INH	%	9.0
	13419715	CHEMBL2422271	Inhibition of PKD1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	12.0	CHEMBL3863	Homo sapiens	INH	%	12.0
	13419716	CHEMBL2422271	Inhibition of PKD1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	72.0	CHEMBL3863	Homo sapiens	INH	%	72.0
	13419717	CHEMBL2422271	Inhibition of PKD1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	44.0	CHEMBL3863	Homo sapiens	INH	%	44.0
	13439771	CHEMBL2429012	Competitive binding affinity to PRKD1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	95.0	CHEMBL3863	Homo sapiens	INH	%	95.0
	13440836	CHEMBL2429579	Inhibition of PKD1 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-11.0	CHEMBL3863	Homo sapiens	INH	%	-11.0
	13445604	CHEMBL2429012	Competitive binding affinity to PRKD1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	96.0	CHEMBL3863	Homo sapiens	INH	%	96.0
	13451591	CHEMBL2429012	Competitive binding affinity to PRKD1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	98.0	CHEMBL3863	Homo sapiens	INH	%	98.0
	13453014	CHEMBL2429579	Inhibition of PKD1 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	-8.0	CHEMBL3863	Homo sapiens	INH	%	-8.0
	13453062	CHEMBL2429579	Inhibition of PKD1 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-13.0	CHEMBL3863	Homo sapiens	INH	%	-13.0
	13465462	CHEMBL2434211	Inhibition of human PKD1 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	76.0	CHEMBL3863	Homo sapiens	Activity	%	76.0
	13465488	CHEMBL2434382	Inhibition of human PKD1 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	99.0	CHEMBL3863	Homo sapiens	Activity	%	99.0
	13465513	CHEMBL2434035	Inhibition of human PKD1 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	62.0	CHEMBL3863	Homo sapiens	Activity	%	62.0
	13465536	CHEMBL2434382	Inhibition of human PKD1 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	43.0	CHEMBL3863	Homo sapiens	Activity	%	43.0
	13466462	CHEMBL2434211	Inhibition of human PKD1 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	80.66	CHEMBL3863	Homo sapiens	Activity	%	80.66
	13466489	CHEMBL2434382	Inhibition of human PKD1 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	75.26	CHEMBL3863	Homo sapiens	Activity	%	75.26
	13466516	CHEMBL2434211	Inhibition of human PKD1 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	107.98	CHEMBL3863	Homo sapiens	Activity	%	107.98
	13466543	CHEMBL2434382	Inhibition of human PKD1 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	44.32	CHEMBL3863	Homo sapiens	Activity	%	44.32
Active	13488459	CHEMBL2439442	Inhibition of human PKD1 at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	13871772	CHEMBL3101233	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
	13966046	CHEMBL3136662	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	54.0	CHEMBL3863	Homo sapiens	INH	%	54.0
	13973321	CHEMBL3135059	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	5.0	CHEMBL3863	Homo sapiens	INH	%	5.0
	13974039	CHEMBL3136631	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	3.0	CHEMBL3863	Homo sapiens	INH	%	3.0
	13974130	CHEMBL3136237	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	76.0	CHEMBL3863	Homo sapiens	INH	%	76.0
	13974221	CHEMBL3135446	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	82.0	CHEMBL3863	Homo sapiens	INH	%	82.0
	13974959	CHEMBL3136981	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	70.0	CHEMBL3863	Homo sapiens	INH	%	70.0
	13975050	CHEMBL3136128	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL3863	Homo sapiens	INH	%	0.0
	13975141	CHEMBL3134746	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	32.5	CHEMBL3863	Homo sapiens	INH	%	32.5
	13975232	CHEMBL3136390	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	26.0	CHEMBL3863	Homo sapiens	INH	%	26.0
	13975875	CHEMBL3135490	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	75.5	CHEMBL3863	Homo sapiens	INH	%	75.5
	13975968	CHEMBL3137164	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	8.0	CHEMBL3863	Homo sapiens	INH	%	8.0
	13976059	CHEMBL3136043	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	44.0	CHEMBL3863	Homo sapiens	INH	%	44.0
	13976150	CHEMBL3135087	Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	54.5	CHEMBL3863	Homo sapiens	INH	%	54.5
	14585303	CHEMBL3241819	Inhibition of human PKD1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	127.0	CHEMBL3863	Homo sapiens	Activity	%	127.0
	14590407	CHEMBL3241994	Inhibition of PRKD1 (unknown origin) at 5 uM	B	Clc1nc(Cl)c2sccc2n1		CHEMBL3236403	<	Inhibition	%	40.0	CHEMBL3863	Homo sapiens	INH	%	40.0
	14648078	CHEMBL3266640	Inhibition of human PKD1 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	14648079	CHEMBL3266640	Inhibition of human PKD1 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	15014023	CHEMBL3364486	Inhibition of PKC-mu (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298414	>	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	15018673	CHEMBL3361565	Inhibition of PKD1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	67.5	CHEMBL3863	Homo sapiens	INH	%	67.5
	15072470	CHEMBL3380104	Inhibition of PKD1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	83.0	CHEMBL3863	Homo sapiens	Activity	%	83.0
	15251858	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	49.0	CHEMBL3863	Homo sapiens	Activity	%	49.0
	15251939	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	39.0	CHEMBL3863	Homo sapiens	Activity	%	39.0
	15252041	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	85.0	CHEMBL3863	Homo sapiens	Activity	%	85.0
	15252686	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	76.0	CHEMBL3863	Homo sapiens	Activity	%	76.0
	15252788	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	69.0	CHEMBL3863	Homo sapiens	Activity	%	69.0
	15252890	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	15253564	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	80.0	CHEMBL3863	Homo sapiens	Activity	%	80.0
	15253666	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	95.0	CHEMBL3863	Homo sapiens	Activity	%	95.0
	15253768	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	81.0	CHEMBL3863	Homo sapiens	Activity	%	81.0
	15254434	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	32.0	CHEMBL3863	Homo sapiens	Activity	%	32.0
	15254536	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	67.0	CHEMBL3863	Homo sapiens	Activity	%	67.0
	15254638	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	69.0	CHEMBL3863	Homo sapiens	Activity	%	69.0
	15255329	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	66.0	CHEMBL3863	Homo sapiens	Activity	%	66.0
	15255431	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	85.0	CHEMBL3863	Homo sapiens	Activity	%	85.0
	15255534	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	80.0	CHEMBL3863	Homo sapiens	Activity	%	80.0
	15256265	CHEMBL3428223	Inhibition of PKD1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	15686138	CHEMBL3606978	Inhibition of PKD1 (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	15686157	CHEMBL3606887	Inhibition of PKD1 (unknown origin) at 2 uM by radioactive filter-binding assay	B	NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I		CHEMBL3605056	>=	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	15735985	CHEMBL3624363	Inhibition of human recombinant PKCmu	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	uM	10.0
	15756849	CHEMBL3630934	Inhibition of PKCmu (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	19.53	CHEMBL3863	Homo sapiens	INH	%	19.53
	15757874	CHEMBL3630934	Inhibition of PKCmu (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	100.3	CHEMBL3863	Homo sapiens	INH	%	100.3
	15758853	CHEMBL3630934	Inhibition of PKCmu (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	12.13	CHEMBL3863	Homo sapiens	INH	%	12.13
	16431969	CHEMBL3750008	Inhibition of human PKCmu using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	uM	10.0
	16451580	CHEMBL3760877	Inhibition of PKD1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	2.1	CHEMBL3863	Homo sapiens	INH	%	2.1
	16451747	CHEMBL3760877	Inhibition of PKD1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	8.4	CHEMBL3863	Homo sapiens	INH	%	8.4
	16495191	CHEMBL3777519	Inhibition of N-terminal His6-tagged recombinant human PKCmu expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	8.0	CHEMBL3863	Homo sapiens	Activity	%	8.0
	16496110	CHEMBL3777519	Inhibition of N-terminal His6-tagged recombinant human PKCmu expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	13.0	CHEMBL3863	Homo sapiens	Activity	%	13.0
Not Active	16496876	CHEMBL3776611	Inhibition of human PKD1 (2 to 912 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	16507178	CHEMBL3778998	Inhibition of recombinant PKD1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	16508900	CHEMBL3777519	Inhibition of N-terminal His6-tagged recombinant human PKCmu expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	9.0	CHEMBL3863	Homo sapiens	Activity	%	9.0
	16612679	CHEMBL3815722	Inhibition of human PKD1 (2 to 912 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-41.0	CHEMBL3863	Homo sapiens	Activity	%	-41.0
	16612680	CHEMBL3815722	Inhibition of human PKD1 (2 to 912 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-53.0	CHEMBL3863	Homo sapiens	Activity	%	-53.0
	16612681	CHEMBL3815722	Inhibition of human PKD1 (2 to 912 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-96.0	CHEMBL3863	Homo sapiens	Activity	%	-96.0
	16612682	CHEMBL3815722	Inhibition of human PKD1 (2 to 912 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-98.0	CHEMBL3863	Homo sapiens	Activity	%	-98.0
	16614599	CHEMBL3815955	Inhibition of human PKCmu at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	2.0	CHEMBL3863	Homo sapiens	INH	%	2.0
	16618118	CHEMBL3816504	Inhibition of PKD1 (unknown origin) at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	16628495	CHEMBL3820307	Inhibition of human recombinant full-length PKD1 expressed in insect Sf21 cells at 1 uM using KKLNRTLSVA as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	16654163	CHEMBL3829161	Inhibition of human PKD1 (2 to 912 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
412045	17776760	CHEMBL3888688	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	=	IC50	nM	2407.0	CHEMBL3863	Homo sapiens	IC50	nM	2407.0
	17982179	CHEMBL3998820	Inhibition of human PKCmu using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	18114813	CHEMBL4025343	Inhibition of wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	18143856	CHEMBL4031846	Inhibition of PKD1 in human PBMC at 1 uM	B	Cc1cccc(-c2cc(N)nc3[nH]cc(C#N)c23)c1		CHEMBL3961632	>	Inhibition	%	35.0	CHEMBL3863	Homo sapiens	INH	%	35.0
	18153238	CHEMBL4034463	Inhibition of PKD1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	1.1	CHEMBL3863	Homo sapiens	INH	%	1.1
	18185968	CHEMBL4040602	Inhibition of N-terminal His6 tagged recombinant human full length PKCmu expressed in Sf21 cells at 10 uM relative to control	B	N#Cc1c[nH]c2nc(N)nc(-c3ccc(S(N)(=O)=O)cc3)c12		CHEMBL4089551	>	Inhibition	%	80.0	CHEMBL3863	Homo sapiens	INH	%	80.0
	18203867	CHEMBL4044154	Inhibition of wild-type human partial length PRKD1 (G551 to E870 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	73.0	CHEMBL3863	Homo sapiens	Activity	%	73.0
	18232175	CHEMBL4050331	Inhibition of human PKD1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	79.0	CHEMBL3863	Homo sapiens	Activity	%	79.0
	18243998	CHEMBL4052948	Inhibition of recombinant full length GST-tagged human PKD1 expressed in baculovirus expression system at 0.1 uM relative to control	B	Cc1cc([C@](C)(O)C#Cc2cc3c(cc2F)OCCn2cc(C(N)=O)nc2-3)no1		CHEMBL4098056	=	Inhibition	%	55.0	CHEMBL3863	Homo sapiens	INH	%	55.0
	18253925	CHEMBL4055247	Inhibition of wild-type human partial length PKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	18253926	CHEMBL4055247	Inhibition of wild-type human partial length PKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL3863	Homo sapiens	Activity	%	96.0
	18282680	CHEMBL4120265	Inhibition of PKD1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.3	CHEMBL3863	Homo sapiens	INH	%	1.3
	18282901	CHEMBL4120486	Inhibition of PKD1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	7.0	CHEMBL3863	Homo sapiens	INH	%	7.0
	18283121	CHEMBL4120706	Inhibition of PKD1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-3.0	CHEMBL3863	Homo sapiens	INH	%	-3.0
	18378350	CHEMBL4145195	Inhibition of recombinant human full length GST-tagged PRKD1 expressed in baculovirus at 1 uM	B	CC[C@@H](C)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C		CHEMBL4169221	=	Inhibition	%	73.0	CHEMBL3863	Homo sapiens	INH	%	73.0
	18440409	CHEMBL4157233	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	18462191	CHEMBL4180878	Inhibition of recombinant human full length His6-tagged PKD1 expressed in Sf21 insect cells assessed as residual activity at 1 uM using KKLNRTLSVA as substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	108.0	CHEMBL3863	Homo sapiens	Activity	%	108.0
	18463792	CHEMBL4181208	Inhibition of recombinant human PKCmu at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	6.0	CHEMBL3863	Homo sapiens	INH	%	6.0
	18484365	CHEMBL4186012	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
	18484849	CHEMBL4186012	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	18507644	CHEMBL4191147	Inhibition of recombinant full-length human PKCmu at 1 uM using KKLNRTLSVA as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-13.0	CHEMBL3863	Homo sapiens	INH	%	-13.0
	18533629	CHEMBL4195752	Inhibition of full length recombinant human GST-tagged PKD1 expressed in baculovirus expression system at 0.1 uM relative to control	B	CN1CC[C@@](O)(C#Cc2ccnc(-n3nc(C(N)=O)c4c3CCCC4)c2)C1=O		CHEMBL4216004	>	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	18533630	CHEMBL4195752	Inhibition of full length recombinant human GST-tagged PKD1 expressed in baculovirus expression system at 0.1 uM relative to control	B	CN1CC[C@@](O)(C#Cc2ccnc(-n3nc(C(N)=O)c4ccccc43)c2)C1=O		CHEMBL4211046	>	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	18533631	CHEMBL4195752	Inhibition of full length recombinant human GST-tagged PKD1 expressed in baculovirus expression system at 0.1 uM relative to control	B	CN1CC[C@@](O)(C#Cc2ccnc(-n3nc(C(N)=O)c4cc(F)ccc43)c2)C1=O		CHEMBL4211551	>	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	18653407	CHEMBL4230202	Inhibition of PRKD1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	4.0	CHEMBL3863	Homo sapiens	INH	%	4.0
	18653408	CHEMBL4230202	Inhibition of PRKD1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	3.0	CHEMBL3863	Homo sapiens	INH	%	3.0
	18655323	CHEMBL4230912	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	18665516	CHEMBL4233392	Inhibition of PRKD1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL3863	Homo sapiens	IC50	nM	1000.0
	18674860	CHEMBL4235422	Inhibition of PRKD1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL3863	Homo sapiens	Ki	nM	2000.0
	18674861	CHEMBL4235422	Inhibition of PRKD1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL3863	Homo sapiens	Ki	nM	2000.0
Not Determined	18674862	CHEMBL4235422	Inhibition of PRKD1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3863	Homo sapiens	Ki		
	18751216	CHEMBL4263925	Inhibition of PRKD1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	2.0	CHEMBL3863	Homo sapiens	INH	%	2.0
	18752164	CHEMBL4264501	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	48.0	CHEMBL3863	Homo sapiens	Activity	%	48.0
	18764485	CHEMBL4267064	Inhibition of human PKD1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	>	Inhibition	%	90.0	CHEMBL3863	Homo sapiens	INH	%	90.0
	18764486	CHEMBL4267064	Inhibition of human PKD1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL3863	Homo sapiens	INH	%	70.0
	18764487	CHEMBL4267064	Inhibition of human PKD1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL3863	Homo sapiens	INH	%	70.0
	18782821	CHEMBL4270687	Inhibition of PKD1 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	12.0	CHEMBL3863	Homo sapiens	Activity	%	12.0
	18857644	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)cn2C2CC3C2)no1		CHEMBL4113471	=	Ki	nM	0.9	CHEMBL3863	Homo sapiens	Ki	nM	0.9
	18857645	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)cn2C2CC3C2)no1		CHEMBL3978002	=	Ki	nM	65.0	CHEMBL3863	Homo sapiens	Ki	nM	65.0
	18857646	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)cn2CCO3)no1		CHEMBL4115120	=	Ki	nM	4.9	CHEMBL3863	Homo sapiens	Ki	nM	4.9
	18857647	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)cn2CCO3)no1		CHEMBL3896516	=	Ki	nM	14.0	CHEMBL3863	Homo sapiens	Ki	nM	14.0
	18857648	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cnc([C@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)cn2C2CC3C2)o1		CHEMBL4109262	<	Ki	nM	0.2	CHEMBL3863	Homo sapiens	Ki	nM	0.2
	18857649	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cnc([C@@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)cn2C2CC3C2)o1		CHEMBL3957252	=	Ki	nM	4.2	CHEMBL3863	Homo sapiens	Ki	nM	4.2
	18857650	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	CCOc1nc2ccc(C#C[C@@](C)(O)c3ncc(C)o3)cc2n1-c1ccnc(N)n1		CHEMBL4524153	=	Ki	nM	3.6	CHEMBL3863	Homo sapiens	Ki	nM	3.6
	18857651	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	CCOc1nc2ccc(C#C[C@](C)(O)c3ncc(C)o3)cc2n1-c1ccnc(N)n1		CHEMBL4546659	=	Ki	nM	62.0	CHEMBL3863	Homo sapiens	Ki	nM	62.0
	18857652	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@](C)(O)C#Cc2cc3c(cc2F)C2CC(C2)n2cc(C(N)=O)nc2-3)no1		CHEMBL4073390	=	Ki	nM	5.9	CHEMBL3863	Homo sapiens	Ki	nM	5.9
	18857653	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@](C)(O)C#Cc2cc3c(cc2F)C2CC(C2)n2c-3nc(C(N)=O)c2C2CC2)no1		CHEMBL4111969	<	Ki	nM	0.2	CHEMBL3863	Homo sapiens	Ki	nM	0.2
	18857654	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	NC(=O)c1cn2c(n1)-c1cc(C#CC3(O)CCCC3)ccc1C1CC2C1		CHEMBL3692392	=	Ki	nM	25.0	CHEMBL3863	Homo sapiens	Ki	nM	25.0
	18857655	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	NC(=O)c1cn2c(n1)-c1cc(C#CC3CCCC3)ccc1C1CC2C1		CHEMBL4461552	=	Ki	nM	44.0	CHEMBL3863	Homo sapiens	Ki	nM	44.0
	18857656	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	CNC(=O)c1c(C(N)=O)nc2n1C1CC(C1)c1ccc(C#CC(C)(C)c3ncc(C)o3)cc1-2		CHEMBL4444206	<	Ki	nM	0.2	CHEMBL3863	Homo sapiens	Ki	nM	0.2
	18857657	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cnc(C(C)(C)C#Cc2ccc3c(c2)-c2nc(C(N)=O)c(C4CC4)n2C2CC3C2)o1		CHEMBL4517096	<	Ki	nM	0.2	CHEMBL3863	Homo sapiens	Ki	nM	0.2
	18857658	CHEMBL4307634	Inhibition of full length GST-tagged human PRKD1 expressed in Baculovirus expression system using ATP as substrate incubated for 1 to 2 hrs by transcreener ADP assay based fluorescence correlation spectroscopic analysis	B	Cc1cc([C@@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)c(C4CC4)n2CCO3)no1		CHEMBL3941082	<	Ki	nM	0.2	CHEMBL3863	Homo sapiens	Ki	nM	0.2
Active	18857695	CHEMBL4307638	Inhibition of full length GST-tagged recombinant human PRKD1 expressed in Baculovirus expression system at 0.1 uM using Fluorescein-CREBtide as substrate incubated for 1 hr by TR-FRET assay relative to control	B	CNC(=O)c1c(C(N)=O)nc2n1C1CC(C1)c1ccc(C#CC(C)(C)c3ncc(C)o3)cc1-2		CHEMBL4444206		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	18857696	CHEMBL4307638	Inhibition of full length GST-tagged recombinant human PRKD1 expressed in Baculovirus expression system at 0.1 uM using Fluorescein-CREBtide as substrate incubated for 1 hr by TR-FRET assay relative to control	B	Cc1cc([C@@](C)(O)C#Cc2ccc3c(c2)-c2nc(C(N)=O)c(C4CC4)n2CCO3)no1		CHEMBL3941082	>	Inhibition	%	30.0	CHEMBL3863	Homo sapiens	INH	%	30.0
	18858164	CHEMBL4308010	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL3863	Homo sapiens	Activity	%	96.0
Not Active	18883531	CHEMBL4312760	Activity at human PKCmu at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL3863	Homo sapiens	Activity		
	18892694	CHEMBL4314555	Inhibition of recombinant full-length human PKCmu R135A mutant assessed as residual activity at 10 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	103.0	CHEMBL3863	Homo sapiens	Activity	%	103.0
	18938229	CHEMBL4327841	Inhibition of human PKCmu assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.71	CHEMBL3863	Homo sapiens	Activity	%	99.71
	18938230	CHEMBL4327841	Inhibition of human PKCmu assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.28	CHEMBL3863	Homo sapiens	Activity	%	100.28
	18938686	CHEMBL4328205	Inhibition of human PKCmu assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3863	Homo sapiens	Activity	%	65.0
	18939070	CHEMBL4328569	Inhibition of human PKCmu using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.6	CHEMBL3863	Homo sapiens	IC50	10'-9M	3.6
	18953733	CHEMBL4331950	Inhibition of PKD1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	60.0	CHEMBL3863	Homo sapiens	INH	%	60.0
	18953785	CHEMBL4331950	Inhibition of PKD1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	34.0	CHEMBL3863	Homo sapiens	INH	%	34.0
	18953864	CHEMBL4331950	Inhibition of PKD1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	70.0	CHEMBL3863	Homo sapiens	INH	%	70.0
	18953956	CHEMBL4332009	Inhibition of PKD1 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	41.0	CHEMBL3863	Homo sapiens	INH	%	41.0
	18954020	CHEMBL4332009	Inhibition of PKD1 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	7.0	CHEMBL3863	Homo sapiens	INH	%	7.0
	18954087	CHEMBL4331950	Inhibition of PKD1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	43.0	CHEMBL3863	Homo sapiens	INH	%	43.0
	18958596	CHEMBL4333595	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	18964608	CHEMBL4335245	Inhibition of recombinant full-length human PKCmu R135A mutant assessed as residual activity at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	18964609	CHEMBL4335245	Inhibition of recombinant full-length human PKCmu R135A mutant assessed as residual activity at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	99.0	CHEMBL3863	Homo sapiens	Activity	%	99.0
	18972058	CHEMBL4337068	Inhibition of recombinant full-length human PKCmu R135A mutant assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
Not Active	19040117	CHEMBL4352020	Inhibition of recombinant full-length human PKCmu R135A mutant at 10 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	19041247	CHEMBL4352508	Inhibition of human PKCmu at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	19059789	CHEMBL4358090	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	19090353	CHEMBL4365927	Inhibition of wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	85.0	CHEMBL3863	Homo sapiens	Activity	%	85.0
	19092079	CHEMBL4366553	Inhibition of human PKCmu at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	25.88	CHEMBL3863	Homo sapiens	INH	%	25.88
	19144805	CHEMBL4377821	Inhibition of recombinant full-length human PKCmu R135A mutant at 1 uM using KKLNRTLSVA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	3.0	CHEMBL3863	Homo sapiens	INH	%	3.0
	19148002	CHEMBL4379228	Inhibition of recombinant full-length human PKCmu R135A mutant using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3863	Homo sapiens	IC50	uM	10.0
	19159617	CHEMBL4382721	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	1.2	CHEMBL3863	Homo sapiens	Activity	%	1.2
	19181121	CHEMBL4387332	Inhibition of recombinant full length human GST-tagged PKD1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	62.5	CHEMBL3863	Homo sapiens	INH	%	62.5
	19181346	CHEMBL4387332	Inhibition of recombinant full length human GST-tagged PKD1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-17 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	98.5	CHEMBL3863	Homo sapiens	INH	%	98.5
	19191390	CHEMBL4389440	Inhibition of wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL3863	Homo sapiens	INH	%	100.0
	19192103	CHEMBL4389917	Inhibition of wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL3863	Homo sapiens	INH	%	100.0
	19200359	CHEMBL4391543	Binding affinity to wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	24.0	CHEMBL3863	Homo sapiens	Activity	%	24.0
	19266574	CHEMBL4405524	Inhibition of PKCmu (unknown origin) at 1 uM relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3863	Homo sapiens	INH	%	50.0
	19276080	CHEMBL4408083	Inhibition of recombinant human full length PKCmu at 1 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	14.0	CHEMBL3863	Homo sapiens	INH	%	14.0
Not Active	19297261	CHEMBL4412717	Inhibition of PKCmu (unknown origin) at 10 uM after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1		CHEMBL4529234		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	20600648	CHEMBL4603600	Inhibition of recombinant full length human GST-tagged PKCmu expressed in baculovirus expression system using serine/threonine-17 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3863	Homo sapiens	IC50	uM	100.0
	22423315	CHEMBL4674233	Inhibition of human PKCmu using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	48.54	CHEMBL3863	Homo sapiens	Activity	%	48.54
	22423316	CHEMBL4674233	Inhibition of human PKCmu using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	4.39	CHEMBL3863	Homo sapiens	Activity	%	4.39
	22843602	CHEMBL4720588	Inhibition of human PKCmu using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.35	CHEMBL3863	Homo sapiens	IC50	10^-9M	1.35
	22843946	CHEMBL4720932	Inhibition of human PKCmu assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.32	CHEMBL3863	Homo sapiens	Activity	%	96.32
	22844834	CHEMBL4721509	Inhibition of wild-type human partial length PRKD1 (G551 to E870 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	46.93	CHEMBL3863	Homo sapiens	Activity	%	46.93
	22883478	CHEMBL4727563	Inhibition of recombinant human full-length GST-tagged PKCmu expressed in baculovirus expression system	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	<=	IC50	nM	500.0	CHEMBL3863	Homo sapiens	IC50	nM	500.0
	22949366	CHEMBL4765788	Inhibition of human PKCmu assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	22949367	CHEMBL4765788	Inhibition of human PKCmu assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	99.0	CHEMBL3863	Homo sapiens	Activity	%	99.0
	22949368	CHEMBL4765788	Inhibition of human PKCmu assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	89.0	CHEMBL3863	Homo sapiens	Activity	%	89.0
	22949369	CHEMBL4765788	Inhibition of human PKCmu assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	95.0	CHEMBL3863	Homo sapiens	Activity	%	95.0
	22949370	CHEMBL4765788	Inhibition of human PKCmu assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	90.0	CHEMBL3863	Homo sapiens	Activity	%	90.0
	22949371	CHEMBL4765788	Inhibition of human PKCmu assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	95.0	CHEMBL3863	Homo sapiens	Activity	%	95.0
	22949372	CHEMBL4765789	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	93.0	CHEMBL3863	Homo sapiens	Activity	%	93.0
	22949373	CHEMBL4765789	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	89.0	CHEMBL3863	Homo sapiens	Activity	%	89.0
	22949374	CHEMBL4765789	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	22949375	CHEMBL4765789	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	72.0	CHEMBL3863	Homo sapiens	Activity	%	72.0
	22949376	CHEMBL4765789	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	91.0	CHEMBL3863	Homo sapiens	Activity	%	91.0
	22949377	CHEMBL4765789	Inhibition of human PKCmu assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	91.0	CHEMBL3863	Homo sapiens	Activity	%	91.0
	22952965	CHEMBL4766902	Inhibition of recombinant full-length human PKCmu assessed as residual activity at 10 uM using KKLNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	89.0	CHEMBL3863	Homo sapiens	Activity	%	89.0
	22986618	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	1013.0	CHEMBL3863	Homo sapiens	IC50	nM	1013.0
	22986619	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4779081	=	IC50	nM	108.0	CHEMBL3863	Homo sapiens	IC50	nM	108.0
	22986620	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	Cn1cc(-c2nn(C(C)(C)C)c3ncnc(N)c23)c2ccccc21		CHEMBL4800579	=	IC50	nM	3319.0	CHEMBL3863	Homo sapiens	IC50	nM	3319.0
	22986621	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(C)n1nc(-c2c[nH]c3cccnc23)c2c(N)ncnc21		CHEMBL4778331	=	IC50	nM	343.0	CHEMBL3863	Homo sapiens	IC50	nM	343.0
	22986622	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572	=	IC50	nM	35.0	CHEMBL3863	Homo sapiens	IC50	nM	35.0
	22986623	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	Nc1ncnc2c1c(-c1cccc3ccccc13)nn2CC1CCNCC1		CHEMBL4776166	=	IC50	nM	64.0	CHEMBL3863	Homo sapiens	IC50	nM	64.0
	22986624	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC(C)(CO)Cn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4790321	=	IC50	nM	50.0	CHEMBL3863	Homo sapiens	IC50	nM	50.0
	22986625	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1		CHEMBL4515390	=	IC50	nM	16.0	CHEMBL3863	Homo sapiens	IC50	nM	16.0
	22986626	CHEMBL4774309	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay	B	CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2n1		CHEMBL4576165	=	IC50	nM	183.0	CHEMBL3863	Homo sapiens	IC50	nM	183.0
	22986645	CHEMBL4774312	Potency index, ratio of 3-IN-PP1 IC50 to test compound IC50 for inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572	=	Ratio IC50		3.0	CHEMBL3863	Homo sapiens	Ratio IC50		3.0
Active	22986648	CHEMBL4774315	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	22986649	CHEMBL4774315	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21		CHEMBL4779081		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	22986650	CHEMBL4774315	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1		CHEMBL4787572		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
Active	22986651	CHEMBL4774315	Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in human PANC-1 cells co-transfected with Myc-CTTN assessed as reduction in PDBu-stimulated CTTN phosphorylation at S298 residues at 20 uM preincubated for 1 hr followed PDBu stimulation and measured after 15 mins by Western blot analysis	B	CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1		CHEMBL4515390		Inhibition	%		CHEMBL3863	Homo sapiens	INH		
	23122774	CHEMBL4805125	Inhibition of human PRKD1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	90.0	CHEMBL3863	Homo sapiens	Activity	%	90.0
	23123469	CHEMBL4805713	Inhibition of human PRKD1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL3863	Homo sapiens	Activity	%	100.0
	23123924	CHEMBL4806168	Inhibition of DNA-tagged human PRKD1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	97.0	CHEMBL3863	Homo sapiens	Activity	%	97.0
	23125028	CHEMBL4806730	Inhibition of human PRKD1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	88.0	CHEMBL3863	Homo sapiens	Activity	%	88.0
	23125029	CHEMBL4806730	Inhibition of human PRKD1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL3863	Homo sapiens	Activity	%	92.0
	23128476	CHEMBL4807967	Inhibition of PKCmu (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	23128477	CHEMBL4807967	Inhibition of PKCmu (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
	23128478	CHEMBL4807967	Inhibition of PKCmu (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3863	Homo sapiens	Activity	%	75.0
Not Active	23317610	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	71.0	CHEMBL3863	Homo sapiens	% Control	%	71.0
Not Active	23318078	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23318744	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	99.0	CHEMBL3863	Homo sapiens	% Control	%	99.0
Not Active	23319228	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	98.0	CHEMBL3863	Homo sapiens	% Control	%	98.0
Not Active	23319865	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	79.4	CHEMBL3863	Homo sapiens	% Control	%	79.4
Not Active	23320340	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23321018	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	95.0	CHEMBL3863	Homo sapiens	% Control	%	95.0
Not Active	23321486	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23322116	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	94.0	CHEMBL3863	Homo sapiens	% Control	%	94.0
Not Active	23322584	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL3863	Homo sapiens	% Control	%	96.0
Not Active	23323273	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	95.0	CHEMBL3863	Homo sapiens	% Control	%	95.0
Not Active	23323741	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23324107	CHEMBL4880726	PKCmu (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	15.0	CHEMBL3863	Homo sapiens	% inhibition	%	15.0
Not Active	23324595	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	81.1	CHEMBL3863	Homo sapiens	% Control	%	81.1
Not Active	23325230	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	85.0	CHEMBL3863	Homo sapiens	% Control	%	85.0
Not Active	23325698	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23326345	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	96.0	CHEMBL3863	Homo sapiens	% Control	%	96.0
Not Active	23326813	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	65.0	CHEMBL3863	Homo sapiens	% Control	%	65.0
Not Active	23327513	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	93.0	CHEMBL3863	Homo sapiens	% Control	%	93.0
Not Active	23327981	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	76.0	CHEMBL3863	Homo sapiens	% Control	%	76.0
Not Active	23328568	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23329036	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23329488	CHEMBL4881195	PKCmu (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	127.0	CHEMBL3863	Homo sapiens	% residual kinase activity	%	127.0
Not Active	23329982	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	85.0	CHEMBL3863	Homo sapiens	% Control	%	85.0
Not Active	23330450	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	79.0	CHEMBL3863	Homo sapiens	% Control	%	79.0
Not Active	23331206	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23331674	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23332261	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	81.2	CHEMBL3863	Homo sapiens	% Control	%	81.2
Not Active	23332727	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23333445	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	95.7	CHEMBL3863	Homo sapiens	% Control	%	95.7
Not Active	23334084	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	90.0	CHEMBL3863	Homo sapiens	% Control	%	90.0
Not Active	23334552	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23334944	CHEMBL4881566	PKCmu  (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	60.0	CHEMBL3863	Homo sapiens	% inhibition	%	60.0
Not Active	23335531	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	55.0	CHEMBL3863	Homo sapiens	% Control	%	55.0
Not Active	23335999	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	74.0	CHEMBL3863	Homo sapiens	% Control	%	74.0
Not Active	23336626	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23337094	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23337745	CHEMBL4882116	PRKD1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	92.0	CHEMBL3863	Homo sapiens	% Ctrl	%	92.0
Not Active	23338175	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23338643	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23339255	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23339723	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23340360	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23340828	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	92.0	CHEMBL3863	Homo sapiens	% Control	%	92.0
Not Active	23341485	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23341953	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23342569	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23343037	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	98.0	CHEMBL3863	Homo sapiens	% Control	%	98.0
Not Active	23343667	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	75.0	CHEMBL3863	Homo sapiens	% Control	%	75.0
Not Active	23344135	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL3863	Homo sapiens	% Control	%	95.0
Not Active	23344773	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23345346	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	89.0	CHEMBL3863	Homo sapiens	% Control	%	89.0
Not Active	23345814	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	96.0	CHEMBL3863	Homo sapiens	% Control	%	96.0
Not Active	23346391	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23346859	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	90.1	CHEMBL3863	Homo sapiens	% Control	%	90.1
Not Active	23347461	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23347951	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	89.4	CHEMBL3863	Homo sapiens	% Control	%	89.4
Not Active	23348530	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23348998	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23349585	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23350203	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23350671	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23351276	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23351744	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	75.0	CHEMBL3863	Homo sapiens	% Control	%	75.0
Not Active	23352198	CHEMBL4882887	PRKD1 (PKC mu) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	13.25	CHEMBL3863	Homo sapiens	% Inhibition	%	13.2544
Not Active	23352768	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	84.0	CHEMBL3863	Homo sapiens	% Control	%	84.0
Not Active	23353236	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	82.0	CHEMBL3863	Homo sapiens	% Control	%	82.0
Not Active	23354118	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23354586	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23355318	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	90.0	CHEMBL3863	Homo sapiens	% Control	%	90.0
Not Active	23355786	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	87.0	CHEMBL3863	Homo sapiens	% Control	%	87.0
Not Active	23356422	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23356890	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23357499	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23358146	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23358614	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23359200	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23359798	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23360266	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	90.0	CHEMBL3863	Homo sapiens	% Control	%	90.0
Not Active	23360851	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	80.0	CHEMBL3863	Homo sapiens	% Control	%	80.0
Not Active	23361319	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	83.0	CHEMBL3863	Homo sapiens	% Control	%	83.0
Not Active	23361892	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	75.0	CHEMBL3863	Homo sapiens	% Control	%	75.0
Not Active	23362428	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	92.0	CHEMBL3863	Homo sapiens	% Control	%	92.0
Not Active	23362896	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	93.0	CHEMBL3863	Homo sapiens	% Control	%	93.0
Not Active	23364538	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	76.0	CHEMBL3863	Homo sapiens	% Control	%	76.0
Not Active	23365006	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	89.0	CHEMBL3863	Homo sapiens	% Control	%	89.0
Not Active	23365745	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23366288	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23366878	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23367346	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23367710	CHEMBL4884063	PKC-mu ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	92.0	CHEMBL3863	Homo sapiens	% Residual activity with Skepinone-L	%	92.0
Not Active	23368224	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23368692	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL3863	Homo sapiens	% Control	%	94.0
Not Active	23369291	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23369759	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23370204	CHEMBL4884446	PKCmu (h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	96.0	CHEMBL3863	Homo sapiens	% residual kinase activity	%	96.0
Not Active	23370727	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23371195	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	92.0	CHEMBL3863	Homo sapiens	% Control	%	92.0
Not Active	23372004	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	93.0	CHEMBL3863	Homo sapiens	% Control	%	93.0
Not Active	23372472	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL3863	Homo sapiens	% Control	%	91.0
	23372867	CHEMBL4884832	PKD1(PRD1LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3863	Homo sapiens	pIC50		6.0
	23373276	CHEMBL4885123	PKD1(PRD1LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3863	Homo sapiens	pIC50		6.0
	23373632	CHEMBL4885409	PKD1(PRD1LHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3863	Homo sapiens	pIC50		6.0
Not Active	23375076	CHEMBL4886064	PKD1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	7.5	CHEMBL3863	Homo sapiens	% Inhibition	%	7.5
Not Active	23375352	CHEMBL4886334	protein kinase D1  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL3863	Homo sapiens	% inhibition	%	-5.0
Not Active	23375899	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	87.0	CHEMBL3863	Homo sapiens	% Control	%	87.0
Not Active	23376367	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	82.0	CHEMBL3863	Homo sapiens	% Control	%	82.0
Not Active	23376944	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23377412	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23378272	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	99.0	CHEMBL3863	Homo sapiens	% Control	%	99.0
Not Active	23378740	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23379907	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	87.0	CHEMBL3863	Homo sapiens	% Control	%	87.0
Not Active	23380375	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	95.0	CHEMBL3863	Homo sapiens	% Control	%	95.0
Not Active	23381069	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	96.0	CHEMBL3863	Homo sapiens	% Control	%	96.0
Not Active	23381717	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23382185	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	86.0	CHEMBL3863	Homo sapiens	% Control	%	86.0
Not Active	23382809	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23383277	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23383958	CHEMBL4887565	PRKD1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	83.0	CHEMBL3863	Homo sapiens	% Ctrl	%	83.0
Not Active	23384425	CHEMBL4888020	PKCmu(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	12.7	CHEMBL3863	Homo sapiens	% inhibition	%	12.7
Not Active	23384699	CHEMBL4888225	PRKD1 (PKC mu) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	10.0	CHEMBL3863	Homo sapiens	% Inhibition	%	10.0
Not Active	23385192	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
Not Active	23385659	CHEMBL4879916	KinomeScan assay: inhibition of PRKD1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3863	Homo sapiens	% Control	%	100.0
